Cancer in Australia 1998 by Stevenson, Chris et al.
	 	
	
 
This is the published version 
 
Stevenson, Chris, Harding, John, van der Hoek, Robert, Christensen, Edith, 
Leeds, Kate, Southgate, Kathy and Nobbs, Amanda 2001, Cancer in Australia 
1998, Australian Institute of Health and Welfare, Canberra, A. C. T 
 
 
 
 
 
 
 
Available from Deakin Research Online 
 
http://hdl.handle.net/10536/DRO/DU:30046734	
	
	
	
	 	
	
	
	
Reproduced with the kind permission of the copyright owner 
	
 
 
 
 
 
Copyright: 2001, Australian Institute of Health and Welfare 
 
 
Cancer in Australia
1998
Incidence and mortality data for 1998
The Australian Institute of Health and Welfare is Australia’s national health and welfare
statistics and information agency. The Institute’s mission is to improve the health and
wellbeing of Australians by informing community discussion and decision making through
national leadership in developing and providing health and welfare statistics and information.
The Australasian Association of Cancer Registries (AACR) is a collaborative body
representing State and Territory cancer registries in Australia and New Zealand. Most are
members of the International Association of Cancer Registries. The AACR was formed in
November 1982 to provide a formal mechanism for promoting uniformity of collection,
classification and collation of cancer data.
The purposes of the AACR are:
• to provide a continuing framework for the development of population-based cancer
registration in Australia and New Zealand;
• to facilitate the exchange of scientific and technical information between cancer registries
and to promote standardisation in the collection and classification of cancer data;
• to facilitate cancer research both nationally and internationally; and
• to facilitate the dissemination of cancer information.
The Australian Institute of Health and Welfare has joined with the AACR to produce national
cancer statistics from the National Cancer Statistics Clearing House.
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Preface
The Australian Institute of Health and Welfare (AIHW) and the Australasian Association of
Cancer Registries (AACR) are pleased to present Cancer in Australia 1998, the most recent
report generated from the National Cancer Statistics Clearing House. This report contains
national cancer incidence and mortality data and also includes data from another of the
AACR members, New Zealand.
The AACR and the AIHW wish to acknowledge the efforts of all the cancer registries in
compiling and providing timely data to the National Cancer Statistics Clearing House so that
this report could be published. We intend to continue to improve the provision of data on
cancer in Australia, undertake a work program that encourages further standardisation of
cancer registry information and increase analysis of the national data collection (for example
survival analysis).
Cancer registration is a legal requirement in all States and Territories. The data are collected
to monitor cancer trends, assist national efforts to understand the causes of cancer, and assist
prevention efforts and treatment decisions. Data confidentiality and the uses to which cancer
registry data can be put are controlled by State and Territory registries (under State and
Territory law) and within the AIHW under the Australian Institute of Health and Welfare Act
1987. The cancer registries, together with the AIHW and community organisations (for
example cancer charity organisations), intend to promote further public awareness of their
data collections and findings. Particular use has been made of the Internet in improving
public access to data by a number of the registries. A home page for the AACR has been
developed on the AIHW’s web site http://www.aihw.gov.au/cancer with links to
Australian and international cancer-related organisations. The national incidence data since
1983 are available on the same site.
Richard Madden Dr Tim Threlfall
Director Chair
Australian Institute of Health and Welfare Australasian Association of Cancer Registries
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Executive summary
This report presents national cancer incidence and mortality statistics for 1998 and is part of
a series of publications concerning cancer patterns in Australia. The State and Territory
cancer registries provide the incidence data for this report whereas the mortality data are
provided by the State and Territory Registrars of Births, Deaths and Marriages and coded by
the Australian Bureau of Statistics.
The main findings are as follows.
New cases of cancer and mortality
• Excluding non-melanocytic skin cancers, there were 80,864 new cancer cases and 34,270
deaths due to cancer in Australia in 1998. At the incidence rates prevailing in 1998, it
would be expected that 1 in 3 men and 1 in 4 women would be directly affected by
cancer in the first 75 years of life. Further, an estimated 260,000 potential years of life
would be lost to the community each year as a result of people dying of cancer before the
age of 75. Cancer currently accounts for 29% of male deaths and 25% of female deaths.
Cancers in males and females
• In males, prostate cancer (9,869 new cases diagnosed in 1998) is the most common
registrable cancer, followed by colorectal cancer (6,131), lung cancer (5,307) and
melanoma (4,398). These four cancers account for 59% of all registrable cancers in males.
• In females, breast cancer (10,665) is the most common registrable cancer, followed by
colorectal cancer (5,158), melanoma (3,493) and lung cancer (2,488). These four cancers
account for 59% of all registrable cancers in females.
Most common cancers causing death
• The most common cancers causing death are lung (4,817), prostate (2,544) and colorectal
(2,475) cancers in males, and breast (2,526), colorectal (2,159) and lung (2,076) cancers in
females.
Age distribution
• The risk of cancer increases with age, with over twice as many cancers diagnosed in
those over the age of 60 as in those under 60.
Trends
• Between 1993 and 1998, age-standardised incidence rates for all cancers combined
(except non-melanocytic skin cancers) declined for males by an average of 1.9% per year
and rose for females by an average of 0.6% per year but death rates declined for both
males and females by an average of 1.7% and 1.3% per year, respectively.
• A significant proportion of the rise in female incidence rates can be attributed to the
continuing increase of breast cancer incidence which in turn can be attributed in part to
detection of prevalent cancers by the breast screening programs. The recent fall in male
incidence rates is strongly influenced by the decline in prostate and lung cancer rates.
The introduction of prostate-specific antigen testing and its later fall in use has induced
the rapid rise and subsequent fall in the rates of the incidence of prostate cancer in recent
years.
xii
• Despite a slight increase in incidence rates for cervical cancer over the last year, between
1993 and 1998 incidence and mortality fell rapidly by an average of 6.9% and 6.5% per
annum, respectively.
Smoking-related new cases and mortality
• Cigarette smoking is estimated to have directly caused 10,506 new cases of cancer (13%
of all new cases of cancer) and 7,068 deaths (21% of cancer deaths) in 1998. Between 1993
and 1998, the male incidence rate for smoking-related cancers fell by an average of 1.2%
per year, while the rate for females rose by 0.3% per year. Over the same period,
mortality rates fell for both males and females by 1.8% and 0.4% per annum respectively.
Alcohol-related new cases and mortality
• It is estimated that 715 new cases of cancer were directly attributable to hazardous and
harmful alcohol consumption in 1998 at a rate of 3.6 cases per 100,000 population, as
were 307 deaths at a rate of 1.5 per 100,000 population.
Comparison with New Zealand
At an international level, New Zealand serves as a good comparison to Australia due to its
similar heritage, economic development and patterns of cancer risk factors. The most
frequently occurring cancers in both countries are very similar. However, when comparing
age-standardised mortality rates, Australia’s female rates are substantially lower than New
Zealand’s for several cancers, with cancers of the breast and lung showing the largest
differences. Cancer incidence and mortality rates in New Zealand males are slightly higher
than those of Australian males for most types of cancer. Incidence rates for melanoma in
both Australia and New Zealand are among the highest in the world, with higher incidence
rates observed in Australia and higher mortality rates in New Zealand.
11 Introduction
Cancer is a notifiable disease in all States and Territories and is the only major disease
category for which an almost complete coverage of incidence data is available. Cancer is also
a major cause of death in Australia. If this situation is to be changed, good information on
the occurrence of different types of cancer, the characteristics of patients, and survival and
mortality is essential. Such information facilitates the monitoring of trends and the impact of
interventions, and provides a sound basis for epidemiological studies and the initiation of
prevention and treatment programs.
What is cancer?
Cancer describes a range of diseases in which abnormal cells proliferate and spread out of
control. Other terms for cancer are tumours and neoplasms, although these terms can also be
used for non-cancerous growths.
Normally, cells grow and multiply in an orderly way and have a specific function in the
body. Occasionally, however, they multiply in an uncontrolled way after being affected by a
carcinogen, or after developing from a random genetic mutation, and form a mass which is
called a tumour or neoplasm. Tumours can be benign (not a cancer) or malignant (a cancer).
Benign tumours do not invade other tissues or spread to other parts of the body, although
they can expand to interfere with healthy structures.
The main features of a malignant tumour (cancer) are its ability to grow in an uncontrolled
way and to invade and spread to other parts of the body (metastasise). Invasion occurs when
cancer cells push between and break through other surrounding cells and structures. Spread
to other parts of the body occurs when some cancer cells are carried by the bloodstream or
the lymphatic system and lodge some distance away. They can then start a new tumour
(a secondary cancer) and begin invading again. They can cause serious damage by
destruction, crushing or blocking.
Cancer can develop from most types of cells in different parts of the body, and each cancer
has its own pattern of growth and spread. Some cancers remain in the body for years
without showing any symptoms. Others can grow, invade and spread rapidly, and are fatal
less than a year after detection. Apart from the cancer’s natural behaviour, its effects can also
depend on how much room it has before it damages nearby structures, and whether it starts
in a vital organ or is close to other vital organs.
Although a number of cancers share risk factors, most cancers have a unique set of risk
factors that are responsible for their onset. Some cancers occur as a direct result of smoking,
dietary influences, infectious agents or exposure to radiation (for example ultraviolet
radiation), while others may be a result of inherited genetic faults. It should be noted that for
most cancers the causes are unknown. While some of the causes are modifiable through
lifestyle changes, some others are inherited and cannot be avoided. However, the risk of
death due to particular cancers may be reduced through intensive monitoring of individuals
at high risk, reducing external risk factors, detecting and treating cancers early in their
development, and treating them in accordance with the best available evidence.
2Many cancers can be serious and even fatal. However, medical treatment is often successful
if the cancer is detected early. The aim is to destroy the cancer cells and stop them from
returning. This can be done by surgery to cut out the growth or by other methods such as
cancer-destroying drugs (chemotherapy) or ray treatment (radiation therapy). The growth of
some cancers can also be controlled through hormone therapy.
The treatment approach often combines a number of these methods and uses them in stages.
The first line of treatment aims to remove as many cancer cells as possible; the second line,
which may go on for a long time, aims to ensure the cancer does not recur.
Cancer surveillance in Australia
National data on cancer deaths have been available since the early 1900s, based on
information in medical certificates of cause of death, as provided to the Registrar of Births,
Deaths and Marriages in each State and Territory. The Australian Institute of Health and
Welfare (AIHW) and the Australian Bureau of Statistics (ABS) use these data to report
national cause of death statistics. Information concerning cancer deaths and non-cancer
deaths of cancer cases is also collected by State and Territory cancer registries, based on
death certificates and other diagnostic information.
The only effective method of obtaining cancer incidence data is through universal
registration of cancer diagnoses. In Australia, cancer registration is required under State and
Territory legislation. The cancer registrations are collated by cancer registries that are
supported by a mix of State and Territory government and non-government charity
organisations. Some State and Territory cancer registries have been operating for nearly
30 years and obtain their information from hospital, pathology, radiotherapy and physician
records (Appendix D). It was not until 1982, however, that cancer registration was universal
in Australia (data were published in Cancer in Australia 1982 (Giles et al. 1987)). Before then,
there was no registration in some States and in some others registries covered only
particular areas, hospitals or cancer sites.
The National Cancer Statistics Clearing House
In June 1984 the National Health and Medical Research Council endorsed the concept of a
national collection of cancer statistics. In April 1985 the National Committee on Health and
Vital Statistics agreed that the National Cancer Statistics Clearing House (NCSCH) should be
operated by the then Australian Institute of Health under the supervision of the
Australasian Association of Cancer Registries (AACR).
Following the enactment of Commonwealth legislation establishing the then Australian
Institute of Health as a statutory body in 1987, and subsequent legislation providing for the
protection of confidentiality of records supplied to it, the Institute and the AACR established
the NCSCH. This provides a facility for compiling data produced by individual State and
Territory registries on a continuing basis.
The aim of the NCSCH is to foster the development and dissemination of national cancer
statistics for Australia and specifically to:
• enable computation and publication of national statistics on cancer;
• allow tracking of interstate movement of cancer cases via record linkage;
3• facilitate exchange of scientific and technical information between cancer registries and
promote standardisation in the collection and classification of cancer data; and
• facilitate cancer research both nationally and internationally.
The NCSCH receives data from individual State and Territory cancer registries on cancers
diagnosed in residents of Australia. This commenced with cases first diagnosed in 1982. The
data items provided to the NCSCH by the State and Territory cancer registries enable record
linkage to be performed and the analysis of cancer by site and behaviour.
The NCSCH produces reports of national incidence and mortality data. Periodically,
analyses of specific cancer sites, cancer histology, differentials in cancer rates by country of
birth, geographical variation, trends over time and survival are undertaken on an
accumulation of data which permits examination of the data in greater depth. The section
‘Related publications’ sets out the range of publications based on these data.
The Australian Health Ministers Advisory Council has funded a project during 2001 to
improve data quality in cancer registry collections through establishing a national minimum
data set of cancer registry definitions in the National Health Data Dictionary. While most of
the data items used in the preparation of reports such as the Cancer in Australia series are
collected and coded consistently by all State and Territory cancer registries, there are some
differences in reporting practices among States, and in reporting between Australia and
other countries.
Reports on national cancer survival patterns for the 20 most common cancers are planned
for release in 2001. The analyses will focus on cancers diagnosed between 1982 and 1997,
with a follow-up period extending to 1999. These will be the first national reports on cancer
survival in Australia.
The NCSCH is able to make available a broad range of statistical data. Data identifying
individuals may only be released to bona fide researchers after a strict scientific and ethical
review process which involves the AACR executive, the AIHW Health Ethics Committee
and the State and Territory cancer registries. General database enquiries and enquiries about
the release of statistical data should be addressed to:
Australian Institute of Health and Welfare
National Cancer Statistics Clearing House
Attention: Dr Chris Stevenson
GPO Box 570
Canberra ACT 2601
Phone: (02) 6244 1041
E-mail: chris.stevenson@aihw.gov.au
4Structure of this report
This report is divided into five major components:
• an introduction and overview of cancer in Australia in 1998;
• summary tables for all cancer sites for 1998;
• a series of data tables for the most common cancer sites, and some less common but
topical cancer sites, for 1998;
• glossary and reference sections;
• appendixes comprising cancer coding system, methods, State and Territory registration
features and a full set of statistical tables which are published separately on the AIHW’s
web site at http://www.aihw.gov.au/publications/can/ca98/index.html.
Introduction and overview
The overview of cancer in Australia provides a selection of highlights from the data tables. It
describes the patterns of cancer incidence and mortality by site, age, sex, and State and
Territory. Trends in cancer incidence and mortality are discussed and a series of graphs are
provided presenting the most common cancers by sex and age group, and trends in national
cancer incidence (1983–1998) and mortality (1983–1999). A comparison between Australia
and New Zealand is made for selected cancers.
Summary tables
Summary tables of incidence and mortality for 1998 for all cancer sites are provided. These
tables list numbers of new cases and deaths, and crude and age-standardised incidence and
mortality rates for Australia. Cumulative rates are given for incidence, while the mortality
tables provide estimates of the person-years of life lost. Sex ratios are presented in both the
incidence and mortality tables.
Series of data tables
The series of data tables for the most common or topical cancers in 1998 contain age-specific,
crude, and age-standardised incidence and mortality rates for males, females and persons
for each cancer site. The order of the tables is based on the International Classification of
Diseases (World Health Organization 1977) (Appendix A). All rates are expressed per
100,000 population and, at the Australian level, are directly age-standardised (Appendix B)
to both the total estimated resident population of Australia at 30 June 1991 and the World
Standard Population (Appendix C). Included in these tables are estimates of the lifetime risk
of contracting each cancer, the person-years of life lost and the numbers of each cancer as a
proportion of the total (excluding non-melanocytic skin cancers).
The data tables also include average annual numbers of new cancer cases and deaths, and
age-standardised incidence and mortality rates for each State and Territory. It should be
noted that the State and Territory incidence and mortality rates have been directly
age-standardised to the total estimated resident population of Australia at 30 June 1991.
Therefore, particular care should be taken not to compare these State and Territory rates
with previous Cancer Series publications—Cancer in Australia 1989–1990 (with
Projections to 1995),  Cancer in Australia 1986–1988 or Cancer in Australia 1983–1985—
5where age standardisation used the World Standard Population. The NCSCH is able to
provide State and Territory rates that have been age-standardised to the World Standard
Population on request or State and Territory cancer registries can be contacted directly.
Appendixes
The appendixes include the International Classification of Diseases coding system; a
methods section providing formulae, explanations and examples of the techniques used to
present the data in the report; population data for Australia for 1998; and a summary table of
State and Territory cancer registry characteristics.
This report, together with a comprehensive set of Excel tables for all cancer sites, is available
on the AIHW’s web site at http://www.aihw.gov.au/publications/can/ca98/index.html.
62 Cancer in Australia
General
Excluding non-melanocytic skin cancers, there were 80,864 new cancer cases and 34,270
deaths due to cancer in Australia in 1998. At the incidence rates prevailing in 1998, it would
be expected that 1 in 3 men and 1 in 4 women would be directly affected by cancer in the
first 75 years of life. Further, an estimated 260,000 potential years of life would be lost to the
community each year as a result of people dying of cancer before the age of 75. Cancer
currently accounts for 29% of male deaths and 25% of female deaths.
In this publication the term ‘cancer site’ is used to represent cancers located in specific
organs or tissues as well as systemic cancers such as leukaemia and lymphoma.
Cancers not reported
Each year, approximately 270,000 new cancer cases of non-melanocytic skin cancer are
diagnosed in Australia. Incidence data for this cancer are not collected on a routine basis by
cancer registries. Estimates for the incidence numbers are derived from data collected by a
national market research company in 1985, 1990 and 1995, and analysis by Staples, Marks
and Giles (1998). In the 1995 survey, 63,745 people aged 14–95 years were interviewed about
treatment for skin cancer and there was follow-up with treating physicians for 63% of the
people who claimed to have had treatment for skin cancer in the last 12 months. From the
survey data Staples, Marks and Giles produced age-standardised incidence rates
(standardised to the World Standard Population) for treated non-melanocytic skin cancers in
1995 of an estimated 1,374 per 100,000 population for males and 857 per 100,000 population
for females. These rates are nineteen times the next most common male cancer (prostate) and
ten times the next most common female cancer (breast), using 1998 data. Despite non-
melanocytic skin cancer’s high incidence rate it has a relatively low mortality rate at 1.6 per
100,000 population compared with the high mortality rates of male lung cancer at 53.2 per
100,000 population, female breast cancer (22.8) and prostate cancer (29.5). Non-melanocytic
skin cancer is excluded from any further comparisons in this publication. The totality of
other cancers is referred to as ‘registrable cancers’.
Most common cancers
Persons
• Among all persons, the combination of cancers of the colon and rectum (11,289 new
cases), often referred to as bowel or colorectal cancer, is the most common registrable
cancer in 1998 (Table 1). Colorectal cancer, breast cancer (10,755), prostate cancer (9,869),
melanoma (7,891), and lung cancer (7,795) together account for 59% of all registrable
cancers in 1998.
7Males
• In males, the most common registrable cancers after prostate cancer are colorectal cancer
(6,131 new cases diagnosed in 1998), lung cancer (5,307) and melanoma (4,398) (Table 1,
Figure 1). These four cancers account for 59% of all registrable cancers in males.
Females
• In females, breast cancer (10,665) is the most common registrable cancer, followed by
colorectal cancer (5,158), melanoma (3,493) and lung cancer (2,488), which in total
account for 59% of all registrable cancers in females.
Cancers causing death
• The cancers most commonly causing death are lung (4,817), prostate (2,544) and
colorectal (2,475) in males, and breast (2,526), colorectal (2,159) and lung (2,076) in
females (Table 1).
PYLL—Person-years of life lost
The number of person-years of life lost due to cancer is generally dominated by the most
common cancers due to the large numbers of cases diagnosed, rather than by those less
common cancers which occur earlier in life. Lung cancer is responsible for the highest
number of person-years of life lost before 75 years of age (45,118 in 1998), followed by
colorectal cancer (31,438) and breast cancer (29,373) (Table 1). Cancer of the brain and
nervous system is responsible for the fourth-highest number of person-years of life lost
(16,685). This contrasts with its ranking as the thirteenth most common cancer (1,327 new
cases diagnosed in 1998). Further, the ratio of person-years of life lost to new cases for cancer
of the brain and nervous system (12.6) is much higher than that for lung cancer (5.8),
colorectal cancer (2.8) or breast cancer (2.7). This is a direct result of the relatively large
number of younger people diagnosed with, and dying from, cancer of the brain and nervous
system.
The most common cancers by age
The most common cancers vary depending on age (Figure 2). In people aged less than 15,
the most common cancers diagnosed are lymphatic leukaemia and cancers of the brain and
central nervous system. These two cancer sites account for 49% of all cancers in this age
group. In those aged 15–44, melanoma and breast cancer are the most common cancers,
while breast, colorectal, melanoma, prostate and lung cancers are predominant in people
aged over 45 years.
The ranking of the most frequently occurring cancers by age group (Figure 2) is based on the
number of new cases, and for those cancers the number of deaths is also shown. However,
some cancers that would be ranked in the top five cancers based on number of deaths (rather
than new cases) are not presented in Figure 2. Cancers which have a substantial number of
deaths in each age group that are not presented in Figure 2 are those of the other endocrine
glands (16 deaths) in the 0–14 age group and cancer of the brain and nervous system (134)
and cancer of the lung (102) in the 15–44 age group. In the age group 45–64, cancers of
unknown primary site (483 deaths), pancreatic cancer (386), cancer of the brain and nervous
system (379) and non-Hodgkin’s lymphoma (348) are responsible for a substantial number
of deaths. Cancers of unknown primary site (1,755 deaths), cancer of the pancreas (1,200)
and non-Hodgkin’s lymphoma (1,076) are also significant causes of death in the 65 and over
age group.
8Table 1: Most frequently occurring cancers in Australia, 1998(a), (b)
New cases Deaths
Cancer site Number
% of all
new
cancer
cases
ASR
(A)
ASR
(W)
Lifetime
risk(c) Number
% of all
cancer
deaths
ASR
(A)
ASR
(W) PYLL(c)
Males
Prostate 9,869 22.6 109.5 73.6 1 in 11 2,544 13.1 29.5 16.5 6,128
Colorectal 6,131 14.1 66.7 47.5 1 in 17 2,475 12.8 27.4 18.5 18,128
Lung 5,307 12.2 58.2 40.3 1 in 20 4,817 24.8 53.2 35.8 30,660
Melanoma 4,398 10.1 46.4 36.1 1 in 26 635 3.2 6.9 5.0 7,315
Bladder 2,068 4.7 22.9 15.1 1 in 57 564 2.9 6.4 3.8 1,985
NHL 1,742 4.0 18.7 6.7 1 in 64 750 3.9 8.3 5.6 6,835
Unknown site 1,629 3.7 18.0 12.2 1 in 71 1,198 6.2 13.3 8.8 8,075
Kidney 1,333 3.1 14.1 10.6 1 in 78 495 2.6 5.4 3.8 4,158
Stomach 1,238 2.8 13.5 9.4 1 in 91 765 3.9 8.5 5.6 5,235
Pancreas 860 2.0 9.4 6.5 1 in 130 814 4.2 8.9 6.1 6,333
All cancers 43,595 100.0 474.6 340.9 1 in 3 19,400 100.0 215.3 143.5 141,030
Females
Breast 10,665 28.6 101.3 83.2 1 in 11 2,526 17.0 22.8 17.4 29,255
Colorectal 5,158 13.8 46.2 33.2 1 in 26 2,159 14.5 18.5 12.7 13,310
Melanoma 3,493 9.7 34.1 28.0 1 in 36 344 2.3 3.0 2.2 3,740
Lung 2,488 6.7 23.0 16.7 1 in 47 2,076 14.0 18.8 13.3 14,458
Unknown site 1,538 4.1 13.1 8.9 1 in 105 1,102 7.4 9.2 6.1 6,038
NHL 1,466 3.9 13.4 10.0 1 in 90 759 5.1 6.6 4.5 5,020
Uterus 1,399 3.8 13.2 10.5 1 in 78 246 1.7 2.1 1.4 1,130
Ovary 1,216 3.3 11.5 9.0 1 in 99 769 5.2 6.9 5.0 6,548
Pancreas 869 2.3 7.5 5.0 1 in 175 805 5.4 6.9 4.5 4,058
Cervix 868 2.3 8.6 7.0 1 in 143 264 1.8 2.4 1.9 3,795
All cancers 37,269 100.0 346.5 268.7 1 in 4 14,870 100.0 130.1 91.9 119,010
Persons
Colorectal 11,289 14.0 55.6 39.9 1 in 21 4,634 13.5 22.5 15.4 31,438
Breast 10,755 13.3 52.9 42.8 1 in 21 2,543 7.4 12.3 9.2 29,373
Prostate 9,869 12.2 49.0 33.9 1 in 12 2,544 7.4 11.9 6.9 6,128
Melanoma 7,891 9.8 39.6 31.7 1 in 30 979 2.8 4.8 3.5 11,055
Lung 7,795 9.6 38.8 27.6 1 in 28 6,893 20.1 34.0 23.6 45,118
NHL 3,208 4.0 15.9 12.0 1 in 75 1,509 4.4 7.3 5.0 11,855
Unknown site 3,167 3.9 15.3 10.4 1 in 86 2,300 6.7 11.0 7.3 14,113
Bladder 2,803 3.5 13.7 9.2 1 in 89 807 2.4 3.8 2.3 2,688
Kidney 2,191 2.7 10.8 8.2 1 in 101 843 2.4 4.1 2.8 6,228
Stomach 1,905 2.4 9.3 6.5 1 in 133 1,193 3.5 5.7 3.9 8,120
All cancers 80,864 100.0 400.5 299.7 1 in 3 34,270 100.0 166.4 144.6 260,040
(a) Rates are expressed per 100,000 population and age standardised to the Australian 1991 Standard Population (ASR (A)) and to the World
Standard Population (ASR (W)). The rates age standardised to the two populations (World and Australia 1991) differ due to the age
distributions of these populations. For example the World population gives more weight to younger age groups where there are fewer
cancers, and consequently the rate is lower compared with the Australian 1991 population. A greater weight is given to the older age groups
in the Australian 1991 population where there are more cancers, and consequently these rates tend to be higher.
(b) Non-melanocytic skin cancer, known to be the most common cancer type, is excluded from this list as it is not a registrable cancer.
(c) These measures are calculated for ages 0–74 years; PYLL refers to person-years of life lost. Methods for the calculation of these measures
are presented in Appendix B.
Note: NHL refers to non-Hodgkin’s lymphoma.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
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Age and sex differences
Cancer occurs more commonly in males than females. The age-standardised incidence rate
in 1998 for all cancers combined (excluding non-melanocytic skin cancers) was 474.6 new
cases per 100,000 for males and 346.5 per 100,000 for females, resulting in an age-adjusted
sex ratio of 1.4. Males have a higher incidence rate for every cancer site, except for monocytic
leukaemia and for cancers of the breast, thyroid, gallbladder, peritoneum, other digestive
organs and parts of the nervous system.
The risk of cancer increases with age. The age-standardised incidence rate in 1998 for all
cancers combined (excluding non-melanocytic skin cancers) was 15.2 per 100,000 population
for people aged less than 15 years; 94.1 per 100,000 population for 15–44 year olds; 657.8 per
100,000 population for 45–64 year olds; and 1,997.3 per 100,000 population for people aged
65 years and over.
Of people diagnosed with cancer, 0.7% of all cancers (excluding non-melanocytic skin
cancers) occur in those aged less than 15 years, 10.1% in the 15–44 age group, 31.8% in the
45–64 age group, and 57.3% in those aged 65 and over. While the pattern of deaths across
age groups is similar to that of incidence, a larger proportion (71.4%) of cancer deaths occurs
in those aged 65 and over. Cervical and testicular cancers are exceptions to the age pattern,
with the number of cases in the 15–44 age group exceeding that in the 45–64 and 65 and over
age groups.
Age-specific incidence and mortality rates vary depending upon the cancer site
(Figures 3–6). For example, lung cancer incidence and mortality rates parallel each other
closely from age group 30–34, rising sharply from ages 25–29 through to 75–79 (men) and
from ages 20–24 through to 70–74 (women) before falling slightly in the oldest age groups.
The age-specific incidence rates for melanoma of the skin, on the other hand, rise much more
steadily across the whole age range. Some cancers, however, have their highest rates in early
or middle life and remain fairly constant in the higher age groups (for example cancer of the
cervix) or even decline with age (for example cancer of the testis).
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Alcohol- and smoking-related cancers
Alcohol and smoking are risk factors for many cancers. In 1998, alcohol-related cancers
accounted for 0.9% of all new cases of cancer, while smoking-related cases accounted for
13.0% of all new cases of cancer. Smoking-related cases also accounted for a large proportion
of deaths from cancer in 1998 (20.6% of all cancer deaths). These data and those in Tables 27
and 28 are derived from a series of age- and sex-specific aetiological fractions developed by
English et al. (1995) and from cancer incidence estimates for specific cancer sites for 1998.
These fractions are based on an analysis of international and Australian studies and estimate
the probability that a specific agent (alcohol or tobacco) causes a specific disease (cancer).
The cancers thought to be directly attributable to smoking (excluding passive smoking) and
alcohol are listed in Table 2.
Table 2: Cancer site and percentage of cancers attributable to alcohol and smoking
Cancer site Males (%) Females (%)
Alcohol-related cancers
Oropharynx 21 8
Oesophagus 14 6
Liver 18 12
Larynx 21 13
Female breast cancer — 3
Smoking-related cancers
Oropharynx 57 51
Oesophagus 54 46
Stomach 14 11
Anus 48 41
Pancreas 24 19
Larynx 73 66
Lung 84 77
Uterus — 10
Cervix — 19
Vulva — 40
Penis 30 —
Bladder 43 36
Renal parenchyma 28 21
Renal pelvis 55 48
Source: English et al. 1995.
It is estimated that 715 new cases of cancer were directly attributable to hazardous and
harmful alcohol consumption in 1998 at a rate of 3.6 cases per 100,000 population, as were
307 deaths at a rate of 1.5 per 100,000 population. While other cancers may be indirectly
caused by alcohol consumption in combination with other risk factors, alcohol is believed to
be the primary causative agent for differing proportions of specific cancers. The mechanism
by which alcohol causes cancer has not been fully determined, but the major metabolite of
ethanol has been shown to be carcinogenic in animal experiments (English et al. 1995). The
lifetime risk of an alcohol-related cancer is 1 in 237 for males and 1 in 289 for females.
Between 1993 and 1998, the incidence rate for alcohol-related cancers in males fell by an
average of 0.8% per annum, while the rate in females increased by 1.2% per annum.
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Smoking-related cancers account for 18.0% of all new cases of cancer in males and 7.1% of all
new cases of cancer in females. This large difference is attributable to the higher rates of
smoking among men than women in the past 30 years. Twenty-five years ago smoking rates
in men were almost double those in women. This is no longer the case. In 1998 25% of men
and 20% of women aged over 14 years were current smokers (AIHW 1999). Organs
associated with the respiratory system are the ones most affected by cigarette smoke, as a
result of the known carcinogens in cigarette smoke such as polycyclic aromatic
hydrocarbons (Table 2). Epidemiological evidence indicates that other cancers, including
cancers of the upper digestive tract, bladder, renal pelvis (kidneys) and pancreas are also
associated with cigarette smoking (English et al. 1995).
Cigarette smoking is estimated to have directly caused 10,500 new cases of cancer (52.4 new
cases per 100,000 population) and 7,100 deaths (35.0 per 100,000 population) in 1998.
Between 1993 and 1998, the male incidence rate for smoking-related cancers fell by an
average of 1.2% per year, while the rate for females rose by 0.3% per year. Over the same
period, mortality rates fell by 1.8% per annum for males and by 0.4% per annum for females
(Figure 10).
To illustrate the improvement in the male mortality rate for smoking-related cancers: if the
1988 age-specific rates were applied to the 1998 male population there would be an
additional 1,112 male deaths due to smoking in 1998. In contrast, the female mortality rate
for smoking-related cancers has increased since 1988. There would be 38 fewer female
deaths in 1998 if the 1988 rates were applied to the 1998 female population.
Cancer rates in the States and Territories, 1994–1998
Cancer incidence and mortality are reported here for the combined period 1994–1998 for all
States and Territories.
Melanoma rates
Cancer incidence is generally similar among States and Territories. However, variation in
the incidence of melanoma among States creates some differences in the overall incidence
rates. An analysis of all cancers combined (excluding non-melanocytic skin cancers) showed
that Queensland had the highest incidence in both males (526.3 per 100,000 population) and
females (362.5 per 100,000 population), while the Northern Territory reported the lowest
incidence with 432.4 cases per 100,000 for males and 323.9 per 100,000 for females
(Figure 7, Table 9).
Melanoma risk is generally highest in the northern areas and lower in the more southerly
areas, showing a correlation to exposure to ultra violet radiation (Jelfs et al. 1994). Age-
standardised mortality ranges from 2.5 deaths per 100,000 population for the Northern
Territory to 5.8 deaths per 100,000 population for Queensland (Table 14).
Incidence rates excluding melanoma
When the impact of melanoma was removed from the comparison, the order of States and
Territories with the highest and lowest cancer incidence rate for males changed with
Tasmania reporting the highest incidence rate for all cancers combined (excluding non-
melanocytic skin cancers and melanoma) among males (482.5 per 100,000 population), and
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the Northern Territory reporting the lowest, with 403.1 cases per 100,000 population. The
remaining States and Territories reported the following rates for males: South Australia
463.0 per 100,000 population, Queensland 458.3, Victoria 456.3, Australian Capital Territory
450.3, New South Wales 444.3 and Western Australia 434.8. For females, Tasmania reported
the highest rate (321.6 per 100,000 population) and Western Australia reported the lowest
(296.4 per 100,000 population). The remaining States and Territories reported the following
rates for females: Victoria 317.9 per 100,000 population, Queensland 314.2, South Australia
309.4 the Northern Territory 306.1, New South Wales 305.0 and the Australian Capital
Territory 304.2.
Mortality rates
The cancer mortality rates reported for males across the States and Territories range from
218.4 per 100,000 population in New South Wales to 242.3 per 100,000 population in
Tasmania. For females, the mortality rates vary from 131.2 per 100,000 population in
Queensland to 169.3 in the Northern Territory (Table 9).
Lung cancer and smoking-related cancers
Lung cancer incidence rates are highest in the Northern Territory (for males 79.5 cases per
100,000 population, for females 42.5) (Table 13). The lowest lung cancer incidence rates are
reported for males in the Australian Capital Territory (41.6 per 100,000 population) and for
females in South Australia (21.8).
State and Territory variations in smoking-related cancers generally reflect those observed for
lung cancer (Table 28). The Northern Territory reported the highest incidence rates for males
and females (110.4 and 42.2 per 100,000 population respectively). The Australian Capital
Territory reported the lowest smoking-related cancer incidence rates for males (64.4 per
100,000 population) and South Australia had the lowest rate for females (22.4). Death rates
from smoking-related cancers were highest in the Northern Territory for both males and
females.
These patterns of incidence probably reflect smoking behaviour approximately 10–20 years
ago, due to the time lag between exposure to carcinogens in the tobacco smoke and the
diagnosis of cancer. Differentials in smoking rates between the States and Territories
reported in the 1995 National Health Survey (ABS 1997) are likely to affect smoking-related
cancer incidence rates in the future. Tasmania (57.3%) reported the highest proportion of
current and ex-smokers, followed by the Northern Territory with 56.0%. The lowest smoking
and ex-smoking rates were found in New South Wales at 49.2%. In the other States and the
Australian Capital Territory the proportions of smokers and ex-smokers ranged from
50% to 53%.
Breast cancer and prostate cancer
The Australian Capital Territory reported the highest incidence rates for breast cancer (104.0
per 100,000), closely followed by Victoria, South Australia, Western Australia and New
South Wales (ranging from 100.9 to 100.0 cases per 100,000 population). The Northern
Territory reported the lowest incidence rate (71.5 cases per 100,000 population) (Table 15).
The Australian Capital Territory reported high rates of prostate cancer (169.6 per 100,000
population), while significantly lower rates were reported in the Northern Territory (84.0 per
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100,000 population) (Table 19), a rate influenced by the low Indigenous population incidence
rates (d’Espaignet et al. 1996). These interstate variations in prostate cancer incidence might
also be explained by differences in the time and rate of uptake of prostate-specific antigen
(PSA) testing in the States and Territories (Smith et al. 1998; Threlfall et al. 1998).
Cervical cancer
There were differences in cervical cancer incidence among the States and Territories. This
probably reflects in part the relative impact of the screening programs in each jurisdiction.
Most of the large States show consistent rates of approximately 9–10 new cases per 100,000
population; however, South Australia shows a substantially lower rate of 7.1 per 100,000
population (Table 16). The Northern Territory, while having relatively small numbers of
new cases, has a very high incidence rate of 18.0 per 100,000 population. A major contributor
to this incidence rate is the high rate of cervical cancer among the Indigenous population,
which d’Espaignet et al. (1996) indicated was up to three times the rate of the
non-Indigenous population. This situation is also reflected in a high mortality rate (8.4
deaths per 100,000 population). This high mortality rate may be an indicator of late-stage
detection of these cancers.
Explanations for variations
Differences in State and Territory cancer incidence rates may be explained by variations in
underlying cancer risk, the availability and utilisation of diagnostic procedures, reporting
and coding inconsistencies, and normal incidence rate fluctuations. A case in point is
bladder cancer (Table 21), where State and Territory comparisons vary by more than 100%.
This is largely due to differences in local coding practices, particularly in regard to the
inclusion or exclusion of tumours of uncertain behaviour. The AACR plans to address this
issue in the near future by standardising coding practices.
Care should be taken when interpreting incidence rates, especially for less common cancers
and for States and Territories with small populations. To reduce the problems of statistical
variation due to a small number of cases, the numbers and rates presented for the States and
Territories in Tables 9 to 28 in this publication are annual averages of the 5-year period
1994–1998. For annual sex- and cancer-specific data, or data cross-classified by other
variables (for example age, geographic area), the State and Territory cancer registries should
be contacted directly.
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International comparison
Cancer incidence and mortality patterns vary internationally. This variation may be the
result of differences in risk factor exposure (for example smoking, diet and ultraviolet
radiation), in genetic susceptibility, in the detection and treatment of cancer, in the level of
cancer registration and in coding practices.
Australia and New Zealand are two of the few countries in which cancer registration occurs
on a national basis. Many countries either have state/province, regional or hospital-based
cancer registries to record cancer incidence, although most countries have national mortality
collections. This publication compares Australia’s cancer incidence and mortality rates with
those of New Zealand. In Cancer in Australia 1997, Australian rates were also compared with
those of several other countries. No more recent data have become available for those
countries, apart from New Zealand. The broader international comparison found in Cancer
in Australia 1997 has consequently not been repeated in this report.
Cancer in New Zealand
New Zealand shares a similar heritage to Australia and a similar level of economic
development. The New Zealand population at 3.8 million is slightly larger than that of
Queensland (3.4 million) and slightly smaller than that of Victoria (4.6 million). New
Zealand serves as a good comparison for Australia in cancer patterns, as the two countries
share similar patterns of cancer risk factors, for example diet, smoking patterns and
ultraviolet radiation exposure, and also share some similarities in their cancer control
programs, for example cervical and breast cancer screening. Both countries have sizeable
Indigenous populations, which exhibit lower life expectancies than the rest of the
population. New Zealand Maoris comprise approximately 14.5% of the total population and
Australia’s Aboriginal and Torres Strait Islander population represents approximately 2.1%
of the total population.
The New Zealand Health Information Service has supplied 1997 incidence and 1998
mortality data (Table 3) that enable a direct comparison of recent rates for cancers between
Australia and New Zealand. These rates have been standardised to the World Standard
Population. Tables 3, 7 and 8 have been used for purposes of comparing the two countries’
cancer patterns.
New Zealand has approximately 16,000 new cases of cancers diagnosed each year and 7,500
deaths as a result of cancer. The most frequently occurring cancers in Australia and New
Zealand are very similar, with prostate, colorectal and lung cancers in males, and breast,
colorectal and melanoma in females being the dominant cancers. The other common cancers
are ranked similarly in the two countries, although the policy for reporting a combination of
all leukaemias (New Zealand) and unknown primary (Australia) in the dominant cancers
makes for some minor variations in the rankings (Tables 1 and 3).
There are differences in the age-standardised incidence rates for all cancers combined
(excluding non-melanocytic skin cancer). New Zealand males (346.6 new cases per 100,000
population) and females (283.3) have rates approximately 2% higher than those of
Australian males and 5% higher than those of Australian females. Mortality rates in males
are 5% higher in New Zealand (151.0 deaths per 100,000 population compared to 143.5).
However, female mortality rates in New Zealand (117.0 deaths per 100,000 population) are
27% higher than those of Australian females (91.9). This difference in female mortality rates
appears to be spread across a range of cancers, some of which are described below.
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Breast cancer incidence rates are similar in both Australian (83.2 new cases per 100,000
population) and New Zealand females (80.2). However, there is a substantial difference in
mortality rates (New Zealand 22.5, Australia 17.4 deaths per 100,000 population). The breast
screening program in Australia has been operating since about 1990 and may have had some
impact on mortality rates. The New Zealand breast screening program only began in 1999
and benefits from this program may not be seen for some time.
Australian and New Zealand prostate incidence rates have been strongly influenced by the
rapidly changing use of PSA testing, showing a dramatic rise and subsequent decline,
although Australia’s rates peaked one year earlier. Mortality rates are approximately 9%
higher in New Zealand (18.0 deaths per 100,000 population compared to 16.5).
There are also differences in the patterns of colorectal cancer between the two countries.
Males in New Zealand (49.5 new cases per 100,000 population) are slightly above their
Australian counterparts (47.5). However, the New Zealand female incidence (38.7), male
mortality (22.4) and female mortality rates (16.5) are substantially higher than the Australian
rates (33.2, 18.5 and 12.7 respectively).
Both Australians and New Zealanders are known for their outdoor lifestyle, which places
both populations at risk of melanoma and non-melanocytic skin cancers from the increased
ultraviolet radiation exposure. This is reflected in high incidence rates of melanoma in both
countries, with Australia having slightly higher rates than New Zealand. Of note in
assessing the melanoma incidence rates is the relatively small difference between males and
females in New Zealand, a sex ratio of 1.1, compared with a ratio of 1.3 for Australia.
Australia had approximately the same sex ratio as New Zealand in the early 1980s. Since
then there has been a significant divergence in rates. Melanoma has a relatively low
mortality rate but New Zealand’s female rate (3.5 deaths per 100,000 population) is about
60% higher than Australia’s rate (2.2).
Lung cancer incidence and mortality rates in New Zealand males are approximately 7%
lower than rates for Australian males. The incidence and mortality rates for New Zealand
females are more than 30% higher than rates for Australian females.
In summary, there appear to be substantial differences in the reported cancer incidence and
mortality rates between New Zealand and Australia for some of the most common cancers.
This would suggest some differences in the impact of particular risk factors and, in relation
to mortality, a difference in the stage at detection and treatment.
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Table 3: Most frequently occurring cancers in New Zealand(a), (b)
New cases 1997 Deaths 1998
Cancer site Number
% of all
new cancer
cases
ASR
(W)
Lifetime
risk(c) Number
% of all
cancer
deaths
ASR
(W) PYLL(c)
Males
Prostate 2,336 27.7 91.4 1 in 10 524 13.5 18.0 1,200
Colorectal 1,193 14.2 49.5 1 in 16 569 14.7 22.4 3,800
Lung 936 11.1 37.6 1 in 22 855 22.1 33.6 5,325
Melanoma 745 8.8 32.2 1 in 29 143 3.7 5.8 1,708
Bladder 374 4.4 14.6 1 in 60 116 3.0 4.0 445
NHL 304 3.6 13.0 1 in 65 150 3.9 6.2 1,718
Leukaemia 287 3.4 12.6 1 in 84 133 3.4 5.2 1,460
Stomach 241 2.9 9.9 1 in 82 183 4.7 7.1 1,390
Kidney 233 2.8 9.8 1 in 92 116 3.0 4.0 445
Brain 142 1.7 6.9 1 in 152 112 2.9 5.0 2,160
Females
Breast 1,990 26.2 80.2 1 in 12 629 17.3 22.5 7,903
Colorectal 1,137 15.0 38.7 1 in 22 554 15.2 16.5 2,988
Melanoma 736 9.7 29.2 1 in 33 105 2.9 3.5 1,270
Lung 602 7.9 22.2 1 in 35 526 14.4 18.1 3,955
Ovary 268 3.5 10.6 1 in 85 177 4.9 6.3 1,823
NHL 283 3.7 9.9 1 in 87 166 4.6 5.1 1,178
Uterus 272 3.6 10.7 1 in 76 85 2.3 2.7 603
Cervix 218 2.9 8.9 1 in 114 77 2.1 2.9 1,143
Leukaemia 235 3.1 8.9 1 in 117 124 3.4 4.0 1,513
Pancreas 160 2.1 4.7 1 in 196 178 4.9 5.3 895
Persons
Prostate 2,336 14.6 40.9 1 in 19 524 7.0 7.4 1,200
Colorectal 2,330 14.6 43.7 1 in 19 1,123 14.9 19.2 6,788
Breast 2,001 12.5 41.7 1 in 22 633 8.4 11.9 7,950
Melanoma 1,481 9.7 30.4 1 in 31 248 3.3 4.6 2,978
Lung 1,538 9.6 28.8 1 in 27 1,381 18.4 24.8 9,280
NHL 587 3.7 11.4 1 in 75 316 4.2 5.7 2,895
Bladder 511 3.2 8.8 1 in 97 169 2.2 2.4 578
Leukaemia 522 3.3 10.5 1 in 99 257 3.4 4.5 2,973
Stomach 401 2.5 7.1 1 in 121 303 4.0 5.1 2,155
Kidney 391 2.4 7.7 1 in 113 169 2.2 2.4 578
(a) Rates are expressed per 100,000 population and age standardised to the World Standard Population ASR (W).
(b) Non-melanocytic skin cancer, known to be the most common cancer type, is excluded from this list, as it is not a registrable cancer.
(c) These measures are calculated for ages 0–74 years; PYLL refers to person-years of life lost. Methods for the calculation of these measures
are presented in Appendix B.
Note: NHL refers to non-Hodgkin’s lymphoma.
Sources: New Zealand Health Information Service 2001; Cancer in Australia 1998, AIHW & AACR 2001.
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3 Cancer trends
National trends in cancer incidence and mortality
National cancer incidence and mortality rates for the most common cancer sites are
presented in Figures 8–14. Incidence data are presented for the period 1983–1998 while
mortality data are presented for the period 1983–1999.
The trends in incidence and mortality rates vary with cancer site. Some rates have shown an
increase since 1983 while others have remained relatively stable or decreased. In assessing
these trends it is important to recognise that small changes in the trend in the most common
cancers (for example breast, prostate) can mean a substantial shift in the numbers of new
cases or deaths, whereas the same shift in less common cancers can have a relatively small
impact. For example, a 1% increase in the breast cancer incidence rate results in an increase
of approximately 106 new cases, whereas the same percentage increase in cervical cancer
incidence would result in approximately 9 new cases.
Between 1993 and 1998, age-standardised incidence rates for all cancers combined
(excluding non-melanocytic skin cancers) declined for males by an average of 1.9% per year
and rose for females by an average of 0.6% per year (Figure 8). These incidence rates have
been strongly influenced by the steady rise in breast cancer incidence and the rise and fall of
prostate cancer incidence during this period. Mortality rates declined for both males and
females by an average of 1.7% and 1.3% respectively per year. The decline in male lung
cancer and prostate cancer deaths is the main contributor to the falling mortality rate for
males.
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Prostate cancer
Prostate cancer incidence rates were relatively stable up until 1989 but between 1990 and
1994 there was a dramatic rise in the number of new cases of prostate cancer registered
(Figure 9). This upward trend has been attributed to increased detection of the disease
through increased investigations, particularly the introduction of PSA testing (introduced
around 1990). However, from 1994 to 1997 the age-standardised prostate cancer incidence
rate fell by 30%. There was virtually no change between the 1997 and 1998 rate. PSA tests are
specifically designed to identify cancers before the onset of clinical symptoms. Many of
these prevalent cancers may not show any symptoms, and therefore would not be detected
except for PSA testing. Much of the rise in the incidence rate of prostate cancer can be
attributed to detection of these prevalent cancers. The recent decline in the incidence rate
indicates a return towards the underlying rate, removing the effect of these previously
undetected cases. The incidence rate is also declining as the number of PSA tests conducted
falls, reducing the number of prevalent cases detected (Smith et al. 1998; Threlfall et al.
1998). The death rate from prostate cancer, which is significantly lower than the incidence
rate, decreased 3.8% per annum between 1993 and 1998.
Breast cancer
Among females, breast cancer is the most frequently diagnosed cancer and it is the most
common cause of cancer-related death. The incidence of breast cancer in females rose from
92.7 cases per 100,000 population in 1993 to its highest ever level of 101.3 cases per 100,000
population in 1998. The breast cancer incidence rate increased on average 0.9% per annum
between 1993 and 1998 (Figure 9). The increase in incidence in female breast cancer in the
50–69 year old age group in 1993 and 1994 was most likely case finding as a result of the
introduction of the national breast cancer screening program, given that the 50–69 year olds
were the main target age group. The breast cancer mortality rates were stable from 1983 to
1994 but have declined since then.
Colorectal cancer
For colorectal cancer, both the male and female incidence rates have remained largely
unchanged since 1993 while mortality rates have fallen steadily: the male rate decreased
1.7% per annum between 1993 and 1998, the female rate decreased 1.8% (Figure 9).
Lung cancer
Between 1993 and 1998, the incidence and mortality of lung cancer among males fell by an
average of 1.8% and 1.9% respectively per year (Figure 10). These declining rates are
attributed to decreased tobacco smoking among men, and represent the lowest incidence
rate (58.2 new cases per 100,000 population) recorded since national data collection began in
1982. In contrast, lung cancer incidence among females increased by 0.8% per annum
between 1993 and 1998. However, the increase in lung cancer incidence is predominantly in
women aged 65 years and over, while rates in younger women have generally remained
stable or fallen. The death rate from lung cancer among females increased on average by
0.3% per annum between 1993 and 1998.
Melanoma
The incidence rate for melanoma among males increased sharply between 1983 and 1988,
some of this increase due to improved registration of this cancer. The rate declined markedly
in 1989, increased consistently until 1997 but declined again sharply in 1998 (Figure 10). The
pattern for women was similar although not quite as pronounced. Mortality rates for males
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decreased by 1.6% per annum between 1993 and 1998 while the female rates increased by 2%
per annum over the same period.
Non-Hodgkin’s lymphoma
The incidence of non-Hodgkin’s lymphoma increased by an average of 1.8% per year in
females and remained stable in males between 1993 and 1998 (Figure 11). The mortality rate
in females with non-Hodgkin’s lymphoma has risen steadily since 1983 and increased by
1.2% annually between 1993 and 1998. The male mortality rate has fluctuated markedly but
on average declined 1.7% per annum between 1993 and 1998.
Cancer of the bladder
The incidence of bladder cancer for males declined between 1983 and 1991 but has increased
since then (Figure 11). It is likely that part of an increase in male incidence since 1991 is a
result of the increased use of screening for prostate cancer leading to a diagnosis of bladder
cancer as part of the diagnostic work-up. The female incidence rate had a similar pattern but
was much less pronounced. Mortality rates have remained relatively stable throughout the
period 1983–1993 but decreased for both males and females between 1993 and 1998—2.2%
per annum and 0.9 % per annum respectively.
Cancer of the stomach
Stomach cancer incidence fell by an average of 2.9% and 3.0% per year for males and females
respectively over the period 1983–1991. This decline has continued for males between 1993
and 1998 but at a slightly reduced rate (2.7% per annum) while the female rate has decreased
marginally (Figure 11). Mortality rates decreased substantially for both sexes over the 1983
to 1999 period.
Leukaemias
The incidence rate for leukaemias in males and females decreased slightly between 1993 and
1998 although there were quite large annual fluctuations (Figure 12). During the same time
the mortality rates decreased by 2.0% per annum for males and by 2.6% per annum for
females.
Brain cancer
Trends in brain cancer between 1983 and 1998 have remained fairly steady but have
fluctuated from year to year (Figure 12).
Cancer of the pancreas
Between 1993 and 1998, the male incidence and mortality rates for cancer of the pancreas fell
annually by an average of 1.0% and 1.8% respectively. In contrast, over the same period, the
female incidence rate increased by an average of 1.0% per year and the female mortality rate
increased by an average of 0.7% per year (Figure 12).
Cervical cancer
The age-standardised incidence rate for cervical cancer declined by an average of 6.9% per
annum between 1993 and 1998 (Figure 13). This decline was achieved despite a sharp rise in
new cases between 1993 and 1994 and between 1997 and 1998. Mortality rates have fallen by
an average of 6.5% per year since 1993. These gains are due, in part, to the success of the
National Cervical Screening Program.
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Cancer of the uterus
The incidence rates for cancer of the uterus have fluctuated from year to year, resulting in an
average annual fall of 0.3% between 1993 and 1998. Mortality rates decreased 2.3% per
annum in the same period (Figure 13).
Cancer of the ovary
The incidence and mortality rates for cancer of the ovary have changed little since 1983 but
the mortality rate decreased by 1.4% per annum between 1993 and 1998 (Figure 13).
Cancer of the kidney
Between 1993 and 1998, male and female incidence rates for cancer of the kidney increased
by an average of 1.7% per annum. Male mortality rates increased marginally while female
rates declined by 2.7% per annum (Figure 14).
Cancer of the testis
The incidence and mortality rates for testicular cancer increased by an average of 1.8% and
1.4% per annum respectively since 1993 (Figure 14).
Cancers of unknown primary site
‘Cancers of unknown primary site’ is a category that captures cancer diagnoses which
cannot be attributed to a particular body site. While some of these cancers have common
features, at least in terms of aetiology, behaviour and outcome, others are a mixed collection.
This makes it difficult to interpret with certainty the patterns of these cancers, particularly
for mortality where often little histological evidence is available to identify a cancer site.
Although there are many cancers in this category, it is important to know the current trends,
given that this cancer group represents about 4% of new cases and 7% of deaths. Mortality
rates remained fairly steady from 1983 to 1998. Between 1983 and 1990 there was little
variation in incidence for both sexes; however, since 1993, male rates have shown an average
annual decline of 1.6% (Figure 14). This may reflect a tendency for clinicians to investigate
cancer cases more extensively, or for males to present earlier with symptoms, before further
investigation becomes unfruitful.
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Cancers of the prostate and breast, and colorectal cancer
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Cancer of the lung, melanoma and smoking-related cancers
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Non-Hodgkin’s lymphoma, and cancers of the bladder and stomach
31
Leukaemias, and cancers of the brain and pancreas
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Cancers of the cervix, uterus and ovary
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Cancers of the kidney and testis, and cancers of unknown primary site
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Analysis of cancers of unknown primary site
Definition
‘Cancers of unknown primary site’ is a term applicable to cancers for which the site of origin
is undetermined, and is generally applicable only to some types of tumours. It does not
generally include tumours of lymphohaematopoietic origin (such as lymphoma, leukaemia
and myeloma) as these are regarded as systemic diseases, and are usually tabulated by their
type, rather than the location at which they are found.  It generally applies to carcinomas,
sarcomas and other tumours for which the available information does not permit an
assessment of the true site of origin.
Sometimes patients are diagnosed with metastatic cancer, but the primary cancer site is not
known. When doctors cannot determine the location of the primary cancer site, patients are
said to have cancer of unknown primary site.
For the purposes of this analysis, cancers of unknown primary site are analysed using the
general-purpose grouping of malignant neoplasms proposed by Berg (1996).
Sex
Between 1983 and 1990 there was little variation in the incidence of cancers of unknown
primary site for both sexes; however, since 1993, male incidence rates have shown an
average annual decline of 1.6% while the female rate declined marginally (Figure 14). The
incidence rates for males are much higher than for females. This could indicate that males
delay presentation and hence treatment and are more likely to present with an unknown
primary cancer.
Histological groups
There is more variation when the cancers are broken down into different histological groups
(Figure 15). Among females, adenocarcinomas are the largest group, on average 60% larger
than the second main contributor, epidermoid carcinomas. The situation is different for
males, for whom the rates of these two groups are approximately equal, especially in the
more recent years. Rates for epidermoid carcinoma for both males and females rose
substantially up to 1989 but have remained relatively unchanged since then. ‘Unspecified
types of cancer’ is the third largest group among cancers of unknown primary site. Both
male and female rates declined sharply for this group in the mid-1980s. Since then the rates
in males have varied from year to year and have declined slightly, on average; the female
rates have remained fairly constant.
Cancers of unknown primary site by State and Territory of
residence
The Northern Territory reported the highest incidence rate for cancers of unknown primary
site for the period 1994–1998 (21.5 per 100,000 population), while Victoria reported the
lowest incidence rate (14.5 per 100,000 population) (Table 24). Most States and Territories
averaged about 15 cases per 100,000 population. The State and Territory rates are more
varied when the cancers are broken down into the different histological groups
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(Tables 4 & 5). The Australian Capital Territory reported higher than average rates for
adenocarcinomas for males. Tasmania and the Northern Territory reported high rates for
unspecified types of cancer for both males and females. Queensland reported high rates for
epidermoid cancers and very low rates for unspecified carcinomas and unspecified types of
cancer for both males and females. In sharp contrast, South Australia reported very low rates
for epidermoid carcinomas but higher rates for the unspecified groups and other specific
carcinomas; these differences may be due to variations in reporting practices.
Age
Both the incidence and mortality rates for unknown primary site for males and females were
highest in 1998 in the 80–84 and 85 and over age groups (Table 24).
Table 4: Age-standardised incidence rates for cases of unknown primary site by cancer type for
males, 1994–1998 combined
Cancer type NSW Vic Qld WA SA Tas ACT NT Aust
Adenocarcinomas 7.4 6.4 6.4 5.6 5.1 7.0 9.9 2.7 6.6
Epidermoid carcinomas 7.6 3.2 11.5 6.3 1.5 4.1 5.7 5.6 6.4
Other specific carcinomas 1.2 0.9 1.0 1.3 5.3 1.0 1.6 4.3 1.5
Other specified types of cancer 0.1 0.1 0.2 2.5 0.0 0.0 0.0 0.0 0.3
Sarcomas & other soft tissue tumours 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1
Unspecified (carcinoma NOS) 0.5 0.6 0.1 0.1 1.2 0.0 0.7 3.3 0.5
Unspecified types of cancer 2.5 5.3 0.5 3.3 4.3 7.0 0.9 8.8 3.2
Table 5: Age-standardised incidence rates for cases of unknown primary site by cancer type for
females, 1994–1998 combined
Cancer type NSW Vic Qld WA SA Tas ACT NT Aust
Adenocarcinomas 6.0 5.7 5.5 4.7 4.6 6.2 5.5 5.1 5.6
Epidermoid carcinomas 4.3 1.7 6.3 3.1 0.5 2.4 3.2 1.4 3.4
Other specific carcinomas 0.7 0.5 0.7 0.5 3.3 0.3 0.7 4.0 0.9
Other specified types of cancer 0.1 0.1 0.0 1.0 0.0 0.1 0.0 0.2 0.1
Sarcomas & other soft tissue tumours 0.1 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.1
Unspecified (carcinoma NOS) 0.2 0.4 0.0 0.1 0.7 0.2 0.2 0.0 0.3
Unspecified types of cancer 1.6 4.1 0.2 2.5 3.5 6.0 1.3 6.7 2.4
Table 6 shows the percentage of each major cancer grouping for which the primary site was
unknown. All States and Territories reported that a large proportion of ‘unspecified types of
cancer’ and ‘unspecified carcinoma’ were of unknown primary site, although the
distribution between these two groups varied, possibly due to variations in reporting
practices.
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Table 6: Cases of unknown primary site as 5-year average percentage of specific cancers and all
cancers (excluding non-melanocytic skin cancer) for persons, 1994–1998 combined
Cancer type NSW Vic Qld WA SA Tas ACT NT Aust
Adenocarcinomas 3.2 2.8 2.9 2.4 2.4 3.0 3.2 2.4 2.9
Epidermoid carcinomas 7.3 3.9 8.3 5.9 2.2 4.2 6.6 4.1 6.3
Leukaemia 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Lymphomas 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other specific carcinomas 7.6 5.8 6.6 6.4 10.6 5.1 9.3 9.1 7.7
Other specified types of cancer 0.1 0.2 0.1 2.7 0.0 0.1 0.0 0.4 0.4
Sarcomas & other soft tissue tumours 1.9 2.5 1.0 3.8 0.0 1.9 1.6 0.0 1.9
Unspecified (carcinoma NOS) 26.7 30.1 26.9 12.7 36.6 15.8 28.6 44.4 28.8
Unspecified types of cancer 29.5 14.1 23.5 43.6 17.7 21.1 35.3 23.7 18.8
All cancers 4.0 3.6 3.7 3.8 3.8 4.2 3.4 4.9 3.8
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Cancers of unknown primary site by cancer type and sex
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4 Incidence and mortality
tables
Guide to interpreting incidence and mortality tables
This section provides information to assist in the interpretation of the tables in this report.
More detailed information on methods is given in Appendix B.
Table features
• Tables are ordered according to the International Classification of Diseases.
• All rates are presented per 100,000 population.
• Age-standardised rates are calculated by the ‘direct method’ (see definition in
Appendix B Methods). Age-standardised rates for Australia use both the total 1991
Australian population and the World Standard Population as the standard populations.
Age-standardised rates for the States and Territories use only the total 1991 Australian
population as the standard population. Therefore, particular care should be taken not
to compare these State and Territory rates with previous Cancer Series publications—
Cancer in Australia 1989–1990 (with Projections to 1995), Cancer in Australia 1986–1988
or Cancer in Australia 1983–1985—where age standardisation used the World Standard
Population.
• The person-years of life lost (PYLL) and lifetime risk estimates are for the ages 0–74
years.
• The confidence intervals used for crude and age-standardised rates are at the 95% level.
• The ‘all cancers’ incidence and mortality estimates exclude non-melanocytic skin
cancers.
• In this publication the term ‘cancer site’ is used to represent cancers located in specific
organs or tissues as well as systemic cancers such as leukaemia and lymphoma.
• In this publication the term ‘melanoma’ refers to melanoma of the skin only. Melanomas
generally occur on the skin, but may also occur on the eye and mucous membranes (such
as the vaginal and nasal cavities).
Comparison of rates
Care should be exercised when interpreting a comparison between incidence or mortality
rates—for example, when comparing different cancers or when comparing the same cancer
in different years. The confidence intervals indicate the likely range of fluctuation of each
rate. Some fluctuations may be within expectations, while others may indicate a change in
the patterns of cancer incidence or mortality. Where small annual numbers of cancer cases or
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deaths are presented in a table, a direct comparison may produce a false perception of
dramatic changes over time and, in these instances, averages over a period of time should be
used. In general, cancer incidence and mortality rates change relatively slowly over time,
although from year to year there may be marked fluctuations due to significant changes in
diagnostic procedures. Changes over the longer term may also reflect changing exposures to
risk factors.
Combining rates
• Age-specific rates may be summed over cancer sites for a particular age and sex.
• Age-specific rates may not be summed across different ages or sexes, but should be
recalculated from the raw data. However, if populations are similar, the crude rates for a
10-year age group will be approximated by the average of the two 5-year age-specific
rates. For comparison within broader age groups, summary rates should be age
standardised.
State and Territory data
In June 2001 cancer incidence data were available to 1998 for all States and Territories, and to
1999 for Tasmania, South Australia and Western Australia.
The Australian data are presented as annual numbers and rates, while the data for each State
and Territory are presented as average annual rates and numbers of cases and deaths based
on the 5-year average 1994–1998. By presenting the data in this manner, natural statistical
variation due to small numbers of cases or deaths within each State and Territory and cancer
site are averaged across the period and provide a more stable and representative rate of
incidence or mortality. Nonetheless, care should be taken in the interpretation of these rates,
especially for less common cancers or for States and Territories with small populations.
All average numbers of cases or deaths per year in the State and Territory tables are rounded
to the nearest integer. Occasionally, the number of cases or deaths will be zero but a small
corresponding rate will appear. This indicates that there were, on average, fewer than 0.5
cases or deaths per year over the 5-year period and, although the rounding process has
made the entry zero, a rate can still be presented at one decimal point.
The data in this report will not correspond exactly to data published by the individual State
and Territory cancer registries due to the 5-year annual averaging, the use of different
standard populations for age-standardisation and the continual updating of data sets by the
cancer registries.
In this report, State and Territory incidence and mortality rates have been directly age
standardised to the total estimated resident population of Australia at 30 June 1991. Care
should be taken not to compare these State and Territory age-standardised rates with
previous Cancer Series publications—Cancer in Australia 1989–1990 (with Projections to 1995),
Cancer in Australia 1986–1988 or Cancer in Australia 1983–1985—where age standardisation
was done using the World Standard Population. However, the NCSCH is able to provide
State and Territory rates that have been age standardised to the World Standard Population
on request or the registries can be contacted directly.
Cancer incidence estimates provided in this publication were made at May 2001. These
estimates may be updated at any time as case details are added, modified or deleted in the
national database. These modifications may occur several years after the initial diagnosis as
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additional case details are received by the State and Territory cancer registries from data
suppliers and then passed to the NCSCH. This may have the impact of making incidence
estimates for the same year incompatible between publications, but for the most part these
changes are very small.
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Summary tables
1998
 Table 7: Incidence summary table, Australia, 1998
Australia 1998 Males Females
AS rate AS rate Cum. rate Sex ratio AS rate AS rate Cum. rate
ICD-9 Cancer site Number (Aust 1991) (World) per cent M:F Number (Aust 1991) (World) per cent
140–208 All cancers (excluding NMSC) 43,595 474.6 340.9 40.2 1.4 37,269 346.5 268.7 30.2
140 Lip 827 8.8 6.8 0.7 3.3 304 2.7 1.9 0.2
141 Tongue 281 3.0 2.4 0.3 2.1 150 1.4 1.1 0.1
142 Salivary gland 121 1.3 0.9 0.1 1.5 96 0.9 0.7 0.1
143 Gum 28 0.3 0.2 0.0 1.3 26 0.2 0.2 0.0
144 Floor of mouth 127 1.3 1.0 0.1 2.3 62 0.6 0.4 0.1
145 Other mouth 143 1.5 1.2 0.2 1.4 116 1.1 0.8 0.1
146 Oropharynx 216 2.2 1.9 0.2 4.0 58 0.5 0.4 0.1
147 Nasopharynx 76 0.8 0.7 0.1 3.1 25 0.3 0.2 0.0
148 Hypopharynx 142 1.5 1.1 0.2 8.3 20 0.2 0.1 0.0
149 Other lip, oral cavity and pharynx 49 0.5 0.4 0.0 4.1 14 0.1 0.1 0.0
141–149 Head and neck 1,183 12.4 9.8 1.2 2.4 567 5.3 4.0 0.5
150 Oesophagus 631 6.9 4.8 0.6 2.2 372 3.2 2.1 0.2
151 Stomach 1,238 13.5 9.4 1.1 2.3 667 5.8 3.9 0.4
152 Small intestine 131 1.4 1.0 0.1 1.3 121 1.1 0.8 0.1
153 Colon 3,680 40.2 28.0 3.4 1.3 3,572 31.9 22.6 2.7
154 Rectum 2,451 26.5 19.5 2.5 1.8 1,586 14.4 10.6 1.3
153–154 Colorectal 6,131 66.7 47.5 5.9 1.4 5,158 46.3 33.2 4.0
155 Liver 447 4.8 3.7 0.5 3.3 156 1.4 1.1 0.1
156 Gallbladder 252 2.8 1.9 0.2 0.9 356 3.1 2.1 0.2
157 Pancreas 860 9.4 6.5 0.8 1.3 869 7.5 5.0 0.6
158 Peritoneum 43 0.5 0.4 0.0 0.6 77 0.7 0.6 0.1
159 Other digestive organs 33 0.4 0.2 0.0 0.7 66 0.5 0.3 0.0
160 Nasal cavity 79 0.8 0.7 0.1 1.9 46 0.4 0.3 0.0
161 Larynx 558 5.9 4.4 0.6 10.3 61 0.6 0.4 0.1
162 Lung 5,307 58.2 40.3 5.2 2.5 2,488 23.0 16.7 2.2
163 Pleura 398 4.3 3.1 0.4 8.2 58 0.5 0.4 0.1
164 Other respiratory organs 37 0.4 0.4 0.0 1.3 30 0.3 0.3 0.0
170 Bone 91 1.0 0.9 0.1 1.2 78 0.8 0.8 0.1
171 Connective tissue 376 4.1 3.2 0.3 1.5 289 2.7 2.2 0.2
172 Skin—melanoma 4,398 46.4 36.1 4.0 1.4 3,493 34.1 28.0 2.9
173 Skin—non-melanocytic (NMSC)*     
174–175 Breast 90 1.0 0.7 0.1    <0.01 10,665 101.3 83.2 9.5
180 Cervix     868 8.6 7.0 0.7
181 Placenta     8 0.1 0.1 0.0
179+182 Uterus     1,399 13.2 10.5 1.3
183 Ovary     1,216 11.5 9.0 1.0
184 Other female genital organs     270 2.4 1.7 0.2
# Gynaecological 3,753 35.6 28.2 3.2
185 Prostate 9,869 109.5 73.6 9.1     
186 Testis 561 6.1 5.3 0.4     
187 Penis & other male genital organs 90 1.0 0.7 0.1     
188 Bladder 2,068 22.9 15.1 1.8 3.5 735 6.5 4.4 0.5
189 Kidney 1,333 14.1 10.6 1.3 1.8 858 8.0 5.9 0.7
190 Eye 145 1.5 1.2 0.1 1.6 104 1.0 0.8 0.1
191 Brain 702 7.4 6.3 0.6 1.4 560 5.4 4.7 0.5
192 Other nervous system 31 0.3 0.3 0.0 1.0 34 0.3 0.4 0.0
193 Thyroid 273 2.8 2.3 0.2 0.4 723 7.3 6.3 0.6
194 Other endocrine 45 0.5 0.5 0.0 1.2 39 0.4 0.4 0.0
195–199 Unknown primary site 1,629 18.0 12.2 1.4 1.4 1,538 13.1 8.9 1.0
200+202 Non-Hodgkin’s lymphoma 1,742 18.7 14.2 1.6 1.4 1,466 13.4 10.0 1.1
201 Hodgkin’s disease 213 2.3 2.1 0.2 1.2 185 2.0 1.8 0.1
200–202 Lymphoma 1,955 21.0 16.3 1.7 1.4 1,651 15.4 11.8 1.3
203 Multiple myeloma 575 6.3 4.3 0.5 1.6 448 3.9 2.6 0.3
204 Lymphatic leukaemia 549 6.0 5.1 0.5 1.6 395 3.7 3.3 0.3
205 Myeloid leukaemia 573 6.3 4.6 0.5 1.6 430 3.9 2.9 0.3
206 Monocytic leukaemia 12 0.1 0.1 0.0 0.9 16 0.1 0.1 0.0
207–208 Other and unspecified leukaemia 75 0.8 0.6 0.1 1.8 56 0.5 0.3 0.0
204–208 Leukaemias 1,209 13.2 10.3 1.0 1.6 897 8.2 6.7 0.6
# Alcohol-related 376 3.9 3.3 0.4 1.2 339 3.3 2.8 0.3
# Smoking-related 7,857 85.3 61.3 7.7 3.4 2,649 25.0 18.8 2.4
Note:  Rates are expressed per 100,000 population and age-standardised (AS rate) to both the Australian 1991 Standard Population and the World Standard Population.
* Non-melanocytic skin cancer incidence data is not routinely collected by State and Territory cancer registries.
# See Appendix A for ICD-9 codes.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
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 Table 8: Mortality summary table, Australia, 1998
Australia 1998 Males Females
AS rate AS rate PYLL Sex ratio AS rate AS rate PYLL
ICD-9 Cancer site Number (Aust 1991) (World) (<75 yrs) M:F Number (Aust 1991) (World) (<75 yrs)
140–208 All cancers (excluding NMSC) 19,400 215.3 143.5 141,030 1.7 14,870 130.1 91.9 119,010
140 Lip 8 0.1 0.1 110 3.2 4 0.0 0.0 3
141 Tongue 132 1.4 1.1 1,718 3.7 42 0.4 0.3 355
142 Salivary gland 49 0.5 0.3 285 2.7 25 0.2 0.1 103
143 Gum 17 0.2 0.1 165 2.2 11 0.1 0.1 80
144 Floor of mouth 31 0.3 0.3 398 4.2 9 0.1 0.1 45
145 Other mouth 36 0.4 0.3 435 1.3 35 0.3 0.2 183
146 Oropharynx 92 1.0 0.7 935 4.1 29 0.2 0.2 208
147 Nasopharynx 38 0.4 0.3 688 2.5 16 0.2 0.1 250
148 Hypopharynx 49 0.5 0.4 430 5.6 12 0.1 0.1 55
149 Other lip, oral cavity and pharynx 24 0.3 0.2 153 5.5 5 0.0 0.0 48
141–149 Head and neck 468 5.0 3.8 5,205 3.2 184 1.6 1.1 1,325
150 Oesophagus 653 7.2 4.9 4,773 2.7 330 2.7 1.7 1,248
151 Stomach 765 8.5 5.6 5,235 2.4 428 3.6 2.4 2,885
152 Small intestine 52 0.6 0.4 430 2.1 31 0.3 0.2 245
153 Colon 1,738 19.2 12.9 12,443 1.4 1,652 14.1 9.6 9,750
154 Rectum 737 8.1 5.5 5,685 1.8 507 4.4 3.1 3,560
153–154 Colorectal 2,475 27.4 18.5 18,128 1.5 2,159 18.5 12.7 13,310
155 Liver 425 4.6 3.3 3,840 2.5 215 1.9 1.3 1,610
156 Gallbladder 138 1.6 1.0 803 0.9 211 1.8 1.2 975
157 Pancreas 814 8.9 6.1 6,333 1.3 805 6.9 4.5 4,058
158 Peritoneum 32 0.3 0.3 370 0.9 41 0.4 0.3 388
159 Other digestive organs 119 1.4 0.8 615 1.4 125 1.0 0.6 490
160 Nasal cavity 35 0.4 0.3 313 2.3 20 0.2 0.1 163
161 Larynx 186 2.0 1.4 1,505 19.5 12 0.1 0.1 93
162 Lung 4,817 53.2 35.8 30,660 2.8 2,076 18.8 13.3 14,458
163 Pleura 211 2.3 1.6 1,370 10.2 26 0.2 0.2 183
164 Other respiratory organs 12 0.1 0.1 240 1.0 14 0.1 0.1 233
170 Bone 49 0.5 0.4 1,355 1.6 37 0.3 0.3 810
171 Connective tissue 111 1.2 0.9 1,595 1.3 97 0.9 0.7 1,420
172 Skin—melanoma 635 6.9 5.0 7,315 2.3 344 3.0 2.2 3,740
173 Skin—non-melanocytic (NMSC) 229 2.6 1.6 1,083 3.2 112 0.8 0.5 278
174–175 Breast 17 0.2 0.1 118    <0.01 2,526 22.8 17.4 29,255
180 Cervix     264 2.4 1.9 3,795
181 Placenta     0 0.0 0.0 0
179+182 Uterus     246 2.1 1.4 1,130
183 Ovary     769 6.9 5.0 6,548
184 Other female genital organs     91 0.7 0.4 298
# Gynaecological 1,370 12.1 8.7 11,770
185 Prostate 2,544 29.5 16.5 6,128     
186 Testis 24 0.3 0.2 693     
187 Penis & other male genital organs 15 0.2 0.1 193     
188 Bladder 564 6.4 3.8 1,985 3.3 243 2.0 1.1 703
189 Kidney 495 5.4 3.8 4,158 1.8 348 3.0 2.0 2,070
190 Eye 16 0.2 0.1 230 1.9 12 0.1 0.1 60
191 Brain 573 6.1 4.9 9,370 1.4 445 4.2 3.4 7,033
192 Other nervous system 8 0.1 0.1 175 2.2 4 0.0 0.0 108
193 Thyroid 37 0.4 0.3 258 1.5 32 0.3 0.2 228
194 Other endocrine 27 0.3 0.3 948 1.2 24 0.2 0.2 640
195–199 Unknown primary site 1,198 13.3 8.8 8,075 1.5 1,102 9.2 6.1 6,038
200+202 Non-Hodgkin’s lymphoma 750 8.3 5.6 6,835 1.3 759 6.6 4.5 5,020
201 Hodgkin’s disease 31 0.3 0.3 533 1.6 21 0.2 0.2 600
200–202 Lymphoma 781 8.6 5.9 7,368 1.3 780 6.8 4.6 5,620
203 Multiple myeloma 328 3.6 2.4 1,963 1.6 275 2.3 1.5 1,335
204 Lymphatic leukaemia 245 2.7 2.1 4,163 1.8 173 1.5 1.2 2,583
205 Myeloid leukaemia 478 5.3 3.7 4,773 1.7 349 3.1 2.2 3,785
206 Monocytic leukaemia 4 0.0 0.0 3 0.7 8 0.1 0.0 25
207–208 Other and unspecified leukaemia 41 0.5 0.3 243 3.0 20 0.2 0.1 128
204–208 Leukaemias 768 8.5 6.0 9,180 1.8 550 4.8 3.5 6,520
# Alcohol-related 210 2.2 1.8 2,603 2.4 96 0.9 0.7 1,191
# Smoking-related 5,314 58.5 40.0 37,043 3.6 1,754 16.1 11.7 13,983
Note:  Rates are expressed per 100,000 population and age-standardised (AS rate) to both the Australian 1991 Standard Population and the World Standard Population.
# See Appendix A for ICD-9 codes.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
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Tables for selected cancers
1998
• Tables of new cases, deaths, incidence and mortality rates for Australia and the States
and Territories for selected cancers.
• Tables for other cancer sites can be found on the AIHW’s web site at
http://www.aihw.gov.au or can be requested in hard copy from the AIHW.
Table 9: All cancers (excluding non-melanocytic skin cancer) (ICD-9 140–172, 174–208)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 140 21.3 121 19.4 261 20.3 39 5.9 24 3.8 63 4.9
5–9 90 13.3 72 11.2 162 12.2 27 4.0 23 3.6 50 3.8
10–14 92 13.7 80 12.5 172 13.1 29 4.3 16 2.5 45 3.4
15–19 169 25.1 131 20.5 300 22.8 32 4.7 33 5.2 65 4.9
20–24 255 36.9 251 37.7 506 37.3 34 4.9 25 3.8 59 4.3
25–29 430 58.3 481 65.6 911 62.0 52 7.1 54 7.4 106 7.2
30–34 551 78.3 839 118.7 1,390 98.6 102 14.5 105 14.9 207 14.7
35–39 804 107.8 1,265 168.9 2,069 138.4 144 19.3 196 26.2 340 22.8
40–44 1,108 158.7 1,900 270.4 3,008 214.7 286 41.0 347 49.4 633 45.2
45–49 1,699 259.4 2,550 392.6 4,249 325.7 493 75.3 584 89.9 1,077 82.6
50–54 2,732 462.1 3,340 585.7 6,072 522.8 877 148.3 871 152.7 1,748 150.5
55–59 3,698 829.0 3,300 765.3 6,998 797.7 1,292 289.6 975 226.1 2,267 258.4
60–64 4,850 1,314.6 3,567 963.7 8,417 1,138.9 1,915 519.1 1,242 335.6 3,157 427.2
65–69 6,658 1,991.7 4,100 1,175.8 10,758 1,575.1 2,733 817.6 1,623 465.4 4,356 637.8
70–74 7,652 2,675.3 4,708 1,427.1 12,360 2,006.7 3,643 1,273.7 2,174 659.0 5,817 944.4
75–79 6,282 3,132.8 4,370 1,631.1 10,652 2,273.9 3,292 1,641.7 2,311 862.6 5,603 1,196.1
80–84 3,799 3,451.1 3,312 1,840.0 7,111 2,451.4 2,479 2,252.0 2,023 1,123.9 4,502 1,552.0
85 and over 2,586 3,786.5 2,882 1,847.4 5,468 2,437.8 1,931 2,827.4 2,244 1,438.4 4,175 1,861.3
Total 43,595  37,269  80,864  19,400  14,870  34,270  
      
Crude rate 467.8 396.0 431.7 208.2 158.0 183.0
95% CI 463.4 – 472.2 392.0 – 400.1 428.8 – 434.7 205.2 – 211.1 155.5 – 160.6 181.0 – 184.9
AS rate (Aust 1991) 474.6 346.5 400.5 215.3 130.1 166.4
95% CI 470.1 – 479.1 343.0 – 350.1 397.7 – 403.3 212.2 – 218.3 128.0 – 132.3 164.7 – 168.2
AS rate (World) 340.9 268.7 299.7 143.5 91.9 114.6
95% CI 337.5 – 344.2 265.8 – 271.7 297.5 – 301.8 141.4 – 145.6 90.3 – 93.5 113.3 – 115.9
Lifetime risk (0–74) 1 in 3 1 in 4 1 in 3 1 in 7 1 in 10 1 in 8
PYLL (0–74)    141,030 119,010 260,040
Per cent of all 
cancers 100.0 100.0 100.0 100.0 100.0 100.0
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 14,981 491.6 12,092 336.1 27,072 401.3 6,501 218.4 5,040 131.9 11,541 167.8
Vic 10,856 491.3 9,258 348.2 20,113 407.4 4,982 229.3 3,989 141.2 8,971 178.1
Qld 8,134 526.3 6,412 362.5 14,546 434.4 3,416 227.5 2,409 131.2 5,825 173.4
WA 3,735 483.9 3,006 331.7 6,741 397.4 1,653 222.7 1,253 134.5 2,906 172.2
SA 3,910 503.4 3,165 344.1 7,074 410.3 1,707 221.4 1,335 134.3 3,042 170.3
Tas 1,223 519.6 979 355.6 2,203 424.2 562 242.3 437 149.0 999 187.7
ACT 516 494.0 448 334.3 964 401.7 226 238.3 198 157.8 424 190.7
NT 206 432.4 160 323.9 366 381.1 89 224.4 61 169.3 149 198.2
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 10: Cancer of the stomach (ICD-9 151)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
5–9 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
10–14 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
15–19 0 0.0 1 0.2 1 0.1 0 0.0 1 0.2 1 0.1
20–24 2 0.3 1 0.2 3 0.2 2 0.3 0 0.0 2 0.1
25–29 8 1.1 4 0.5 12 0.8 1 0.1 2 0.3 3 0.2
30–34 7 1.0 8 1.1 15 1.1 2 0.3 3 0.4 5 0.4
35–39 19 2.5 8 1.1 27 1.8 8 1.1 6 0.8 14 0.9
40–44 21 3.0 22 3.1 43 3.1 11 1.6 14 2.0 25 1.8
45–49 47 7.2 25 3.8 72 5.5 14 2.1 15 2.3 29 2.2
50–54 90 15.2 29 5.1 119 10.2 47 7.9 21 3.7 68 5.9
55–59 86 19.3 28 6.5 114 13.0 48 10.8 13 3.0 61 7.0
60–64 136 36.9 50 13.5 186 25.2 73 19.8 31 8.4 104 14.1
65–69 177 52.9 71 20.4 248 36.3 102 30.5 39 11.2 141 20.6
70–74 232 81.1 100 30.3 332 53.9 152 53.1 53 16.1 205 33.3
75–79 200 99.7 106 39.6 306 65.3 133 66.3 65 24.3 198 42.3
80–84 123 111.7 94 52.2 217 74.8 89 80.9 68 37.8 157 54.1
85 and over 90 131.8 120 76.9 210 93.6 83 121.5 97 62.2 180 80.2
Total 1,238  667  1,905  765  428  1,193  
      
Crude rate 13.3 7.1 10.2 8.2 4.5 6.4
95% CI 12.5 – 14.0 6.5 – 7.6 9.7 – 10.6 7.6 – 8.8 4.1 – 5.0 6.0 – 6.7
AS rate (Aust 1991) 13.5 5.8 9.3 8.5 3.6 5.7
95% CI 12.7 – 14.3 5.3 – 6.2 8.9 – 9.7 7.9 – 9.1 3.2 – 3.9 5.4 – 6.1
AS rate (World) 9.4 3.9 6.5 5.6 2.4 3.9
95% CI 8.8 – 9.9 3.6 – 4.3 6.2 – 6.8 5.2 – 6.0 2.2 – 2.7 3.6 – 4.1
Lifetime risk (0–74) 1 in 91 1 in 234 1 in 133 1 in 157 1 in 415 1 in 232
PYLL (0–74)    5,235 2,885 8,120
Per cent of all 
cancers 2.8 1.8 2.4 3.9 2.9 3.5
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 419 13.8 224 5.8 643 9.4 251 8.4 139 3.5 390 5.6
Vic 337 15.3 190 6.7 528 10.5 217 10.0 133 4.5 349 6.9
Qld 201 13.3 107 5.7 308 9.2 131 8.8 70 3.6 201 5.9
WA 105 13.8 61 6.5 166 9.9 72 9.6 44 4.6 116 6.9
SA 106 13.7 61 6.0 167 9.3 76 9.9 49 4.8 125 6.9
Tas 34 14.7 20 6.6 54 10.2 29 12.7 16 5.2 46 8.5
ACT 13 12.7 8 6.9 21 9.4 9 9.8 7 5.9 16 7.6
NT 4 11.4 2 4.5 6 7.8 1 2.5 2 4.9 3 3.7
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 11: Cancer of the colon and rectum (ICD-9 153–154)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
5–9 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
10–14 4 0.6 1 0.2 5 0.4 1 0.1 0 0.0 1 0.1
15–19 1 0.1 4 0.6 5 0.4 0 0.0 2 0.3 2 0.2
20–24 7 1.0 4 0.6 11 0.8 1 0.1 0 0.0 1 0.1
25–29 17 2.3 13 1.8 30 2.0 4 0.5 1 0.1 5 0.3
30–34 26 3.7 25 3.5 51 3.6 12 1.7 7 1.0 19 1.3
35–39 56 7.5 55 7.3 111 7.4 19 2.5 13 1.7 32 2.1
40–44 115 16.5 105 14.9 220 15.7 38 5.4 34 4.8 72 5.1
45–49 215 32.8 182 28.0 397 30.4 70 10.7 74 11.4 144 11.0
50–54 373 63.1 296 51.9 669 57.6 105 17.8 94 16.5 199 17.1
55–59 612 137.2 410 95.1 1,022 116.5 213 47.7 125 29.0 338 38.5
60–64 749 203.0 552 149.1 1,301 176.0 276 74.8 179 48.4 455 61.6
65–69 1,033 309.0 664 190.4 1,697 248.5 368 110.1 249 71.4 617 90.3
70–74 1,144 400.0 822 249.2 1,966 319.2 456 159.4 326 98.8 782 127.0
75–79 870 433.9 787 293.7 1,657 353.7 373 186.0 370 138.1 743 158.6
80–84 538 488.7 655 363.9 1,193 411.3 320 290.7 277 153.9 597 205.8
85 and over 371 543.2 583 373.7 954 425.3 219 320.7 408 261.5 627 279.5
Total 6,131  5,158  11,289  2,475  2,159  4,634  
      
Crude rate 65.8 54.8 60.3 26.6 22.9 24.7
95% CI 64.1 – 67.4 53.3 – 56.3 59.2 – 61.4 25.5 – 27.6 22.0 – 23.9 24.0 – 25.5
AS rate (Aust 1991) 66.7 46.3 55.6 27.4 18.5 22.5
95% CI 65.0 – 68.4 45.0 – 47.5 54.6 – 56.6 26.3 – 28.4 17.7 – 19.3 21.8 – 23.1
AS rate (World) 47.5 33.2 39.9 18.5 12.7 15.4
95% CI 46.3 – 48.7 32.2 – 34.2 39.1 – 40.6 17.7 – 19.2 12.1 – 13.3 14.9 – 15.8
Lifetime risk (0–74) 1 in 17 1 in 26 1 in 21 1 in 47 1 in 71 1 in 57
PYLL (0–74)    18,128 13,310 31,438
Per cent of all 
cancers 14.1 13.8 14.0 12.8 14.5 13.5
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 2,049 67.0 1,690 45.0 3,739 54.9 822 27.5 695 17.7 1,517 22.0
Vic 1,554 70.2 1,313 47.2 2,868 57.6 676 30.9 598 20.5 1,274 25.2
Qld 1,069 69.2 892 49.4 1,961 58.7 430 28.6 354 19.0 784 23.4
WA 499 65.0 400 43.6 899 53.3 217 28.9 177 18.6 394 23.3
SA 533 68.2 474 48.1 1,007 57.2 218 28.0 195 19.0 413 23.0
Tas 154 65.1 149 51.3 303 57.8 80 33.9 76 25.2 155 29.2
ACT 68 63.0 53 41.9 121 51.9 33 32.9 26 21.0 59 26.7
NT 24 54.4 15 42.0 39 49.1 8 20.5 7 20.2 15 20.8
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 12: Cancer of the pancreas (ICD-9 157)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
5–9 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
10–14 1 0.1 0 0.0 1 0.1 0 0.0 0 0.0 0 0.0
15–19 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
20–24 1 0.1 2 0.3 3 0.2 0 0.0 0 0.0 0 0.0
25–29 0 0.0 1 0.1 1 0.1 2 0.3 1 0.1 3 0.2
30–34 2 0.3 0 0.0 2 0.1 3 0.4 0 0.0 3 0.2
35–39 7 0.9 3 0.4 10 0.7 3 0.4 2 0.3 5 0.3
40–44 14 2.0 8 1.1 22 1.6 14 2.0 8 1.1 22 1.6
45–49 34 5.2 16 2.5 50 3.8 35 5.3 16 2.5 51 3.9
50–54 60 10.1 34 6.0 94 8.1 44 7.4 31 5.4 75 6.5
55–59 65 14.6 46 10.7 111 12.7 75 16.8 41 9.5 116 13.2
60–64 89 24.1 80 21.6 169 22.9 79 21.4 65 17.6 144 19.5
65–69 140 41.9 99 28.4 239 35.0 124 37.1 91 26.1 215 31.5
70–74 157 54.9 144 43.6 301 48.9 144 50.3 130 39.4 274 44.5
75–79 128 63.8 166 62.0 294 62.8 130 64.8 157 58.6 287 61.3
80–84 83 75.4 133 73.9 216 74.5 82 74.5 126 70.0 208 71.7
85 and over 79 115.7 137 87.8 216 96.3 79 115.7 137 87.8 216 96.3
Total 860  869  1,729  814  805  1,619  
      
Crude rate 9.2 9.2 9.2 8.7 8.6 8.6
95% CI 8.6 – 9.8 8.6 – 9.8 8.8 – 9.7 8.1 – 9.3 8.0 – 9.1 8.2 – 9.1
AS rate (Aust 1991) 9.4 7.5 8.4 8.9 6.9 7.8
95% CI 8.8 – 10.1 7.0 – 8.0 8.0 – 8.8 8.3 – 9.6 6.4 – 7.4 7.4 – 8.2
AS rate (World) 6.5 5.0 5.7 6.1 4.5 5.3
95% CI 6.1 – 7.0 4.6 – 5.4 5.4 – 6.0 5.7 – 6.6 4.2 – 4.9 5.0 – 5.6
Lifetime risk (0–74) 1 in 130 1 in 175 1 in 150 1 in 142 1 in 197 1 in 165
PYLL (0–74)    6,333 4,058 10,390
Per cent of all 
cancers 2.0 2.3 2.1 4.2 5.4 4.7
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 282 9.4 285 7.3 568 8.2 259 8.6 277 7.0 536 7.7
Vic 219 9.9 211 7.2 429 8.5 211 9.7 209 7.1 420 8.3
Qld 148 9.7 129 7.0 278 8.3 142 9.4 124 6.6 266 7.9
WA 72 9.4 71 7.6 143 8.5 69 9.2 65 6.8 134 8.0
SA 73 9.3 79 7.6 151 8.4 70 8.9 73 6.8 142 7.8
Tas 22 9.7 25 8.5 48 9.0 22 9.4 24 7.7 45 8.5
ACT 9 9.2 9 7.3 17 8.0 10 10.4 8 6.7 18 8.3
NT 4 6.8 3 9.4 7 8.5 3 5.2 2 8.9 6 7.5
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 13: Cancer of the trachea, bronchus and lung (ICD-9 162)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 1 0.2 0 0.0 1 0.1 0 0.0 0 0.0 0 0.0
5–9 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
10–14 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
15–19 0 0.0 2 0.3 2 0.2 1 0.1 0 0.0 1 0.1
20–24 3 0.4 1 0.2 4 0.3 2 0.3 0 0.0 2 0.1
25–29 1 0.1 2 0.3 3 0.2 1 0.1 1 0.1 2 0.1
30–34 5 0.7 10 1.4 15 1.1 2 0.3 4 0.6 6 0.4
35–39 24 3.2 20 2.7 44 2.9 13 1.7 9 1.2 22 1.5
40–44 58 8.3 43 6.1 101 7.2 40 5.7 29 4.1 69 4.9
45–49 113 17.3 84 12.9 197 15.1 93 14.2 58 8.9 151 11.6
50–54 267 45.2 151 26.5 418 36.0 201 34.0 117 20.5 318 27.4
55–59 379 85.0 209 48.5 588 67.0 327 73.3 164 38.0 491 56.0
60–64 667 180.8 269 72.7 936 126.6 551 149.3 203 54.8 754 102.0
65–69 978 292.6 392 112.4 1,370 200.6 833 249.2 305 87.5 1,138 166.6
70–74 1,156 404.2 497 150.6 1,653 268.4 1,056 369.2 415 125.8 1,471 238.8
75–79 922 459.8 406 151.5 1,328 283.5 855 426.4 355 132.5 1,210 258.3
80–84 440 399.7 255 141.7 695 239.6 520 472.4 252 140.0 772 266.1
85 and over 293 429.0 147 94.2 440 196.2 322 471.5 164 105.1 486 216.7
Total 5,307  2,488  7,795  4,817  2,076  6,893  
      
Crude rate 56.9 26.4 41.6 51.7 22.1 36.8
95% CI 55.4 – 58.5 25.4 – 27.5 40.7 – 42.5 50.2 – 53.1 21.1 – 23.0 35.9 – 37.7
AS rate (Aust 1991) 58.2 23.0 38.8 53.2 18.8 34.0
95% CI 56.6 – 59.8 22.0 – 23.9 37.9 – 39.6 51.6 – 54.7 18.0 – 19.6 33.2 – 34.8
AS rate (World) 40.3 16.7 27.6 35.8 13.3 23.6
95% CI 39.2 – 41.4 16.0 – 17.4 26.9 – 28.2 34.8 – 36.9 12.7 – 14.0 23.0 – 24.2
Lifetime risk (0–74) 1 in 20 1 in 47 1 in 28 1 in 23 1 in 59 1 in 33
PYLL (0–74)    30,660 14,458 45,118
Per cent of all 
cancers 12.2 6.7 9.6 24.8 14.0 20.1
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 1,811 59.6 834 22.8 2,646 39.0 1,607 53.3 703 18.8 2,309 33.8
Vic 1,343 60.8 635 23.4 1,978 40.0 1,231 56.1 554 20.1 1,786 35.9
Qld 965 63.0 389 22.1 1,354 40.9 858 56.6 318 18.0 1,176 35.5
WA 466 62.1 218 24.5 684 41.3 409 55.2 179 19.9 588 35.5
SA 477 60.9 206 21.8 684 38.9 415 53.2 165 17.1 581 32.8
Tas 162 68.0 72 25.8 234 44.8 144 61.2 57 20.2 201 38.3
ACT 40 41.6 31 25.2 71 32.2 46 47.7 25 20.6 71 32.4
NT 34 79.5 15 42.5 49 62.7 31 84.2 12 31.6 43 58.5
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 14: Cancer of the skin—melanoma (ICD-9 172)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 0 0.0 1 0.2 1 0.1 0 0.0 0 0.0 0 0.0
5–9 1 0.1 1 0.2 2 0.2 0 0.0 0 0.0 0 0.0
10–14 6 0.9 6 0.9 12 0.9 0 0.0 0 0.0 0 0.0
15–19 27 4.0 38 5.9 65 4.9 0 0.0 1 0.2 1 0.1
20–24 53 7.7 93 14.0 146 10.8 1 0.1 0 0.0 1 0.1
25–29 120 16.3 150 20.5 270 18.4 11 1.5 5 0.7 16 1.1
30–34 156 22.2 242 34.2 398 28.2 13 1.8 11 1.6 24 1.7
35–39 232 31.1 259 34.6 491 32.9 21 2.8 12 1.6 33 2.2
40–44 261 37.4 311 44.3 572 40.8 22 3.2 16 2.3 38 2.7
45–49 395 60.3 308 47.4 703 53.9 40 6.1 19 2.9 59 4.5
50–54 457 77.3 355 62.2 812 69.9 49 8.3 19 3.3 68 5.9
55–59 445 99.8 286 66.3 731 83.3 41 9.2 21 4.9 62 7.1
60–64 420 113.8 296 80.0 716 96.9 75 20.3 29 7.8 104 14.1
65–69 487 145.7 276 79.1 763 111.7 74 22.1 30 8.6 104 15.2
70–74 502 175.5 266 80.6 768 124.7 109 38.1 41 12.4 150 24.4
75–79 452 225.4 265 98.9 717 153.1 75 37.4 37 13.8 112 23.9
80–84 239 217.1 171 95.0 410 141.3 60 54.5 46 25.6 106 36.5
85 and over 145 212.3 169 108.3 314 140.0 44 64.4 57 36.5 101 45.0
Total 4,398  3,493  7,891  635  344  979  
      
Crude rate 47.2 37.1 42.1 6.8 3.7 5.2
95% CI 45.8 – 48.6 35.9 – 38.3 41.2 – 43.1 6.3 – 7.3 3.3 – 4.0 4.9 – 5.6
AS rate (Aust 1991) 46.4 34.1 39.6 6.9 3.0 4.8
95% CI 45.0 – 47.8 33.0 – 35.2 38.7 – 40.4 6.3 – 7.4 2.7 – 3.4 4.5 – 5.1
AS rate (World) 36.1 28.0 31.7 5.0 2.2 3.5
95% CI 35.0 – 37.2 27.0 – 29.0 31.0 – 32.4 4.6 – 5.4 1.9 – 2.5 3.3 – 3.7
Lifetime risk (0–74) 1 in 26 1 in 36 1 in 30 1 in 177 1 in 433 1 in 254
PYLL (0–74)    7,315 3,740 11,055
Per cent of all 
cancers 10.1 9.4 9.8 3.3 2.3 2.9
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 1,471 47.3 1,067 31.2 2,538 38.3 231 7.6 112 3.0 343 5.1
Vic 796 35.0 765 30.4 1,561 32.2 130 5.8 79 2.8 209 4.2
Qld 1,100 68.0 830 48.3 1,930 57.3 131 8.4 66 3.6 197 5.8
WA 409 49.1 317 35.3 726 41.6 52 6.7 30 3.2 81 4.8
SA 312 40.3 293 34.7 604 36.9 40 5.1 26 2.9 66 3.9
Tas 88 37.1 88 34.0 176 35.1 10 4.1 6 2.3 16 3.1
ACT 55 43.7 43 30.1 98 36.3 6 5.6 5 3.5 10 4.2
NT 21 29.4 14 17.8 36 23.9 2 3.8 0 0.8 2 2.5
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 15: Cancer of the breast (ICD-9 174–175)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
5–9 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
10–14 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
15–19 0 0.0 4 0.6 4 0.3 0 0.0 0 0.0 0 0.0
20–24 1 0.1 13 2.0 14 1.0 0 0.0 2 0.3 2 0.1
25–29 0 0.0 52 7.1 52 3.5 0 0.0 9 1.2 9 0.6
30–34 0 0.0 196 27.7 196 13.9 0 0.0 26 3.7 26 1.8
35–39 2 0.3 413 55.1 415 27.8 0 0.0 67 8.9 67 4.5
40–44 3 0.4 852 121.3 855 61.0 0 0.0 126 17.9 126 9.0
45–49 7 1.1 1,170 180.1 1,177 90.2 1 0.2 198 30.5 199 15.3
50–54 3 0.5 1,460 256.0 1,463 126.0 1 0.2 260 45.6 261 22.5
55–59 9 2.0 1,261 292.5 1,270 144.8 1 0.2 229 53.1 230 26.2
60–64 17 4.6 1,140 308.0 1,157 156.6 2 0.5 256 69.2 258 34.9
65–69 16 4.8 1,137 326.1 1,153 168.8 2 0.6 243 69.7 245 35.9
70–74 12 4.2 1,054 319.5 1,066 173.1 4 1.4 274 83.1 278 45.1
75–79 11 5.5 875 326.6 886 189.1 3 1.5 296 110.5 299 63.8
80–84 6 5.5 574 318.9 580 199.9 2 1.8 240 133.3 242 83.4
85 and over 3 4.4 464 297.4 467 208.2 1 1.5 300 192.3 301 134.2
Total 90  10,665  10,755  17  2,526  2,543  
      
Crude rate 1.0 113.3 57.4 0.2 26.8 13.6
95% CI 0.8 – 1.2 111.2 – 115.5 56.3 – 58.5 0.1 – 0.3 25.8 – 27.9 13.0 – 14.1
AS rate (Aust 1991) 1.0 101.3 52.9 0.2 22.8 12.3
95% CI 0.8 – 1.2 99.4 – 103.3 51.9 – 53.9 0.1 – 0.3 21.9 – 23.7 11.8 – 12.8
AS rate (World) 0.7 83.2 42.8 0.1 17.4 9.2
95% CI 0.6 – 0.9 81.5 – 84.8 41.9 – 43.6 0.1 – 0.2 16.7 – 18.2 8.8 – 9.5
Lifetime risk (0–74) 1 in 1,110 1 in 11 1 in 21 1 in 6,484 1 in 53 1 in 103
PYLL (0–74)    118 29,255 29,373
Per cent of all 
cancers 0.2 28.6 13.3 0.1 17.0 7.4
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 26 0.8 3,493 100.0 3,519 52.4 6 0.2 880 24.0 886 13.0
Vic 18 0.8 2,604 100.9 2,622 53.3 6 0.3 718 26.5 724 14.5
Qld 14 0.9 1,698 96.7 1,712 50.1 4 0.3 432 23.8 436 12.7
WA 6 0.8 901 100.2 907 51.8 1 0.1 225 24.1 226 12.9
SA 6 0.8 886 100.5 892 53.0 1 0.2 242 25.4 243 13.9
Tas 3 1.1 254 94.9 257 49.9 0 0.2 65 22.8 65 12.3
ACT 1 1.3 147 104.0 148 55.0 0 0.2 40 31.0 40 17.0
NT 1 1.2 44 71.5 45 33.5 0 0.0 8 19.5 8 9.2
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 16: Cancer of the cervix (ICD-9 180)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 0 0.0 0 0.0
5–9 0 0.0 0 0.0
10–14 0 0.0 0 0.0
15–19 1 0.2 0 0.0
20–24 13 2.0 3 0.5
25–29 47 6.4 6 0.8
30–34 85 12.0 4 0.6
35–39 101 13.5 20 2.7
40–44 103 14.7 19 2.7
45–49 110 16.9 16 2.5
50–54 65 11.4 23 4.0
55–59 55 12.8 14 3.2
60–64 55 14.9 30 8.1
65–69 60 17.2 22 6.3
70–74 61 18.5 29 8.8
75–79 44 16.4 23 8.6
80–84 39 21.7 25 13.9
85 and over 29 18.6 30 19.2
Total 868  264  
  
Crude rate 9.2 2.8
95% CI 8.6 – 9.8 2.5 – 3.1
AS rate (Aust 1991) 8.6 2.4
95% CI 8.0 – 9.2 2.1 – 2.7
AS rate (World) 7.0 1.9
95% CI 6.6 – 7.5 1.6 – 2.1
Lifetime risk (0–74) 1 in 143 1 in 499
PYLL (0–74)  3,795
Per cent of all 
cancers 2.3 1.8
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 319 9.5 113 3.1
Vic 236 9.5 69 2.6
Qld 176 10.3 52 3.0
WA 92 10.2 30 3.2
SA 58 7.1 20 2.1
Tas 27 11.0 12 4.6
ACT 13 8.5 5 3.5
NT 11 18.0 4 8.4
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 17: Cancer of the uterus (ICD-9 179+182)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 0 0.0 0 0.0
5–9 0 0.0 0 0.0
10–14 0 0.0 0 0.0
15–19 0 0.0 0 0.0
20–24 3 0.5 0 0.0
25–29 4 0.5 0 0.0
30–34 6 0.8 0 0.0
35–39 24 3.2 0 0.0
40–44 48 6.8 1 0.1
45–49 83 12.8 3 0.5
50–54 152 26.7 7 1.2
55–59 190 44.1 15 3.5
60–64 203 54.8 19 5.1
65–69 176 50.5 30 8.6
70–74 194 58.8 53 16.1
75–79 139 51.9 37 13.8
80–84 98 54.4 38 21.1
85 and over 79 50.6 43 27.6
Total 1,399  246  
  
Crude rate 14.9 2.6
95% CI 14.1 – 15.6 2.3 – 2.9
AS rate (Aust 1991) 13.2 2.1
95% CI 12.5 – 13.9 1.8 – 2.4
AS rate (World) 10.5 1.4
95% CI 9.9 – 11.1 1.2 – 1.6
Lifetime risk (0–74) 1 in 78 1 in 570
PYLL (0–74)  1,130
Per cent of all 
cancers 3.8 1.7
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 436 12.2 89 2.3
Vic 396 15.2 71 2.5
Qld 237 13.6 45 2.4
WA 101 11.4 23 2.4
SA 138 15.1 25 2.4
Tas 34 12.5 7 2.5
ACT 18 14.4 3 2.9
NT 5 9.7 2 5.6
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 18: Cancer of the ovary and other uterine adnexae (ICD-9 183)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 0 0.0 0 0.0
5–9 1 0.2 0 0.0
10–14 4 0.6 1 0.2
15–19 4 0.6 1 0.2
20–24 15 2.3 0 0.0
25–29 27 3.7 2 0.3
30–34 31 4.4 4 0.6
35–39 47 6.3 4 0.5
40–44 46 6.5 17 2.4
45–49 82 12.6 29 4.5
50–54 120 21.0 70 12.3
55–59 131 30.4 69 16.0
60–64 116 31.3 71 19.2
65–69 145 41.6 95 27.2
70–74 140 42.4 112 33.9
75–79 137 51.1 114 42.5
80–84 101 56.1 106 58.9
85 and over 69 44.2 74 47.4
Total 1,216  769  
  
Crude rate 12.9 8.2
95% CI 12.2 – 13.6 7.6 – 8.7
AS rate (Aust 1991) 11.5 6.9
95% CI 10.8 – 12.1 6.4 – 7.4
AS rate (World) 9.0 5.0
95% CI 8.5 – 9.6 4.6 – 5.4
Lifetime risk (0–74) 1 in 99 1 in 171
PYLL (0–74)  6,548
Per cent of all 
cancers 3.3 5.2
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 369 10.4 256 6.9
Vic 366 14.1 218 8.0
Qld 192 10.9 115 6.4
WA 89 10.0 64 7.0
SA 87 9.6 66 7.0
Tas 36 13.3 24 8.2
ACT 14 10.2 11 8.1
NT 5 8.6 2 4.4
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 19: Cancer of the prostate  (ICD-9 185)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 1 0.2 0 0.0
5–9 0 0.0 0 0.0
10–14 0 0.0 0 0.0
15–19 0 0.0 0 0.0
20–24 0 0.0 0 0.0
25–29 0 0.0 0 0.0
30–34 0 0.0 1 0.1
35–39 2 0.3 0 0.0
40–44 16 2.3 2 0.3
45–49 83 12.7 8 1.2
50–54 347 58.7 26 4.4
55–59 816 182.9 51 11.4
60–64 1,215 329.3 119 32.3
65–69 1,795 537.0 227 67.9
70–74 1,999 698.9 453 158.4
75–79 1,720 857.8 535 266.8
80–84 1,122 1,019.3 590 536.0
85 and over 753 1,102.6 532 779.0
Total 9,869  2,544  
  
Crude rate 105.9 27.3
95% CI 103.8 – 108.0 26.2 – 28.4
AS rate (Aust 1991) 109.5 29.5
95% CI 107.4 – 111.7 28.4 – 30.7
AS rate (World) 73.6 16.5
95% CI 72.1 – 75.1 15.8 – 17.2
Lifetime risk (0–74) 1 in 11 1 in 73
PYLL (0–74)  6,128
Per cent of all 
cancers 22.6 13.1
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 3,913 130.1 870 30.9
Vic 2,701 124.3 685 33.2
Qld 1,713 115.3 458 32.5
WA 990 132.6 202 29.6
SA 1,126 144.7 232 31.0
Tas 343 147.5 83 37.2
ACT 161 169.6 27 33.9
NT 28 84.0 5 20.6
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
56
Table 20: Cancer of the testis (ICD-9 186)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 6 0.9 0 0.0
5–9 0 0.0 0 0.0
10–14 1 0.1 0 0.0
15–19 25 3.7 1 0.1
20–24 54 7.8 0 0.0
25–29 91 12.3 2 0.3
30–34 110 15.6 6 0.9
35–39 92 12.3 2 0.3
40–44 85 12.2 1 0.1
45–49 34 5.2 4 0.6
50–54 31 5.2 0 0.0
55–59 12 2.7 2 0.4
60–64 4 1.1 2 0.5
65–69 7 2.1 1 0.3
70–74 2 0.7 0 0.0
75–79 6 3.0 0 0.0
80–84 1 0.9 2 1.8
85 and over 0 0.0 1 1.5
Total 561  24  
  
Crude rate 6.0 0.3
95% CI 5.5 – 6.5 0.2 – 0.4
AS rate (Aust 1991) 6.1 0.3
95% CI 5.6 – 6.6 0.2 – 0.4
AS rate (World) 5.3 0.2
95% CI 4.9 – 5.8 0.1 – 0.3
Lifetime risk (0–74) 1 in 244 1 in 5,580
PYLL (0–74)  693
Per cent of all 
cancers 1.3 0.1
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 188 6.1 10 0.3
Vic 133 5.9 7 0.3
Qld 97 5.9 7 0.4
WA 50 5.5 2 0.2
SA 47 6.5 2 0.3
Tas 14 6.3 0 0.1
ACT 12 7.5 0 0.1
NT 4 3.5 0 0.0
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 21: Cancer of the bladder (ICD-9 188)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
5–9 0 0.0 1 0.2 1 0.1 0 0.0 0 0.0 0 0.0
10–14 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
15–19 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
20–24 2 0.3 3 0.5 5 0.4 0 0.0 0 0.0 0 0.0
25–29 4 0.5 2 0.3 6 0.4 0 0.0 0 0.0 0 0.0
30–34 5 0.7 7 1.0 12 0.9 0 0.0 1 0.1 1 0.1
35–39 12 1.6 6 0.8 18 1.2 0 0.0 1 0.1 1 0.1
40–44 31 4.4 2 0.3 33 2.4 1 0.1 1 0.1 2 0.1
45–49 50 7.6 18 2.8 68 5.2 7 1.1 0 0.0 7 0.5
50–54 97 16.4 26 4.6 123 10.6 16 2.7 7 1.2 23 2.0
55–59 123 27.6 35 8.1 158 18.0 18 4.0 3 0.7 21 2.4
60–64 187 50.7 73 19.7 260 35.2 33 8.9 9 2.4 42 5.7
65–69 303 90.6 93 26.7 396 58.0 55 16.5 23 6.6 78 11.4
70–74 443 154.9 136 41.2 579 94.0 104 36.4 38 11.5 142 23.1
75–79 360 179.5 134 50.0 494 105.5 125 62.3 44 16.4 169 36.1
80–84 260 236.2 110 61.1 370 127.6 100 90.8 62 34.4 162 55.8
85 and over 191 279.7 89 57.0 280 124.8 105 153.7 54 34.6 159 70.9
Total 2,068  735  2,803  564  243  807  
      
Crude rate 22.2 7.8 15.0 6.1 2.6 4.3
95% CI 21.2 – 23.1 7.2 – 8.4 14.4 – 15.5 5.6 – 6.6 2.3 – 2.9 4.0 – 4.6
AS rate (Aust 1991) 22.9 6.5 13.7 6.4 2.0 3.8
95% CI 21.9 – 23.9 6.0 – 7.0 13.2 – 14.2 5.9 – 7.0 1.7 – 2.2 3.5 – 4.1
AS rate (World) 15.1 4.4 9.2 3.8 1.1 2.3
95% CI 14.4 – 15.7 4.1 – 4.8 8.9 – 9.6 3.5 – 4.1 1.0 – 1.3 2.1 – 2.4
Lifetime risk (0–74) 1 in 57 1 in 189 1 in 89 1 in 287 1 in 874 1 in 442
PYLL (0–74)    1,985 703 2,688
Per cent of all 
cancers 4.7 2.0 3.5 2.9 1.6 2.4
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 553 18.5 202 5.2 755 10.9 191 6.7 83 2.0 274 3.9
Vic 661 30.2 213 7.5 874 17.4 141 6.7 59 1.9 200 3.8
Qld 452 29.9 152 8.4 605 18.1 97 6.8 45 2.3 142 4.2
WA 103 14.3 31 3.4 134 8.1 42 6.0 17 1.7 59 3.5
SA 126 16.4 44 4.2 170 9.5 54 7.2 23 2.1 77 4.1
Tas 67 28.7 21 6.9 87 16.5 15 6.7 7 2.0 21 3.9
ACT 17 18.7 4 3.6 21 10.0 8 9.9 3 2.2 11 5.3
NT 5 12.5 1 2.8 6 7.7 3 7.9 1 1.8 3 4.7
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 22: Cancer of the kidney and other and unspecified urinary organs (ICD-9 189)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 10 1.5 9 1.4 19 1.5 2 0.3 1 0.2 3 0.2
5–9 3 0.4 5 0.8 8 0.6 1 0.1 1 0.2 2 0.2
10–14 1 0.1 1 0.2 2 0.2 0 0.0 0 0.0 0 0.0
15–19 1 0.1 2 0.3 3 0.2 2 0.3 0 0.0 2 0.2
20–24 2 0.3 1 0.2 3 0.2 0 0.0 1 0.2 1 0.1
25–29 7 0.9 3 0.4 10 0.7 1 0.1 0 0.0 1 0.1
30–34 15 2.1 10 1.4 25 1.8 3 0.4 0 0.0 3 0.2
35–39 23 3.1 23 3.1 46 3.1 3 0.4 3 0.4 6 0.4
40–44 44 6.3 29 4.1 73 5.2 11 1.6 3 0.4 14 1.0
45–49 83 12.7 36 5.5 119 9.1 9 1.4 9 1.4 18 1.4
50–54 128 21.7 54 9.5 182 15.7 31 5.2 12 2.1 43 3.7
55–59 154 34.5 64 14.8 218 24.8 47 10.5 24 5.6 71 8.1
60–64 131 35.5 76 20.5 207 28.0 55 14.9 27 7.3 82 11.1
65–69 183 54.7 127 36.4 310 45.4 69 20.6 33 9.5 102 14.9
70–74 241 84.3 140 42.4 381 61.9 85 29.7 58 17.6 143 23.2
75–79 168 83.8 134 50.0 302 64.5 84 41.9 60 22.4 144 30.7
80–84 94 85.4 92 51.1 186 64.1 54 49.1 65 36.1 119 41.0
85 and over 45 65.9 52 33.3 97 43.2 38 55.6 51 32.7 89 39.7
Total 1,333  858  2,191  495  348  843  
      
Crude rate 14.3 9.1 11.7 5.3 3.7 4.5
95% CI 13.5 – 15.1 8.5 – 9.7 11.2 – 12.2 4.8 – 5.8 3.3 – 4.1 4.2 – 4.8
AS rate (Aust 1991) 14.1 8.0 10.8 5.4 3.0 4.1
95% CI 13.4 – 14.9 7.4 – 8.5 10.4 – 11.3 4.9 – 5.9 2.7 – 3.3 3.8 – 4.4
AS rate (World) 10.6 5.9 8.2 3.8 2.0 2.8
95% CI 10.0 – 11.2 5.5 – 6.4 7.8 – 8.5 3.4 – 4.1 1.8 – 2.2 2.6 – 3.0
Lifetime risk (0–74) 1 in 78 1 in 142 1 in 101 1 in 234 1 in 448 1 in 310
PYLL (0–74)    4,158 2,070 6,228
Per cent of all 
cancers 3.1 2.3 2.7 2.6 2.3 2.5
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 432 13.9 300 8.2 732 10.8 159 5.3 131 3.4 290 4.2
Vic 302 13.4 188 7.1 490 10.0 122 5.6 77 2.7 199 4.0
Qld 234 14.9 153 8.6 387 11.6 87 5.7 61 3.3 148 4.4
WA 77 9.8 55 6.0 132 7.8 35 4.7 27 2.9 62 3.7
SA 114 14.6 64 6.9 179 10.4 44 5.6 26 2.6 69 4.0
Tas 36 15.0 20 6.9 55 10.7 16 6.9 9 3.0 25 4.7
ACT 14 12.6 8 6.3 22 9.3 6 6.1 5 4.3 11 5.1
NT 6 11.8 3 6.2 9 9.2 1 2.6 1 5.4 2 4.4
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 23: Cancer of the brain (ICD-9 191)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 17 2.6 22 3.5 39 3.0 15 2.3 10 1.6 25 1.9
5–9 25 3.7 23 3.6 48 3.6 5 0.7 7 1.1 12 0.9
10–14 19 2.8 15 2.3 34 2.6 1 0.1 2 0.3 3 0.2
15–19 13 1.9 12 1.9 25 1.9 5 0.7 3 0.5 8 0.6
20–24 18 2.6 10 1.5 28 2.1 2 0.3 7 1.1 9 0.7
25–29 22 3.0 19 2.6 41 2.8 9 1.2 3 0.4 12 0.8
30–34 16 2.3 20 2.8 36 2.6 15 2.1 12 1.7 27 1.9
35–39 28 3.8 27 3.6 55 3.7 16 2.1 8 1.1 24 1.6
40–44 35 5.0 27 3.8 62 4.4 22 3.2 28 4.0 50 3.6
45–49 52 7.9 33 5.1 85 6.5 40 6.1 30 4.6 70 5.4
50–54 63 10.7 34 6.0 97 8.4 68 11.5 35 6.1 103 8.9
55–59 70 15.7 38 8.8 108 12.3 53 11.9 37 8.6 90 10.3
60–64 71 19.2 47 12.7 118 16.0 64 17.3 49 13.2 113 15.3
65–69 67 20.0 40 11.5 107 15.7 76 22.7 37 10.6 113 16.5
70–74 75 26.2 68 20.6 143 23.2 73 25.5 63 19.1 136 22.1
75–79 64 31.9 54 20.2 118 25.2 63 31.4 42 15.7 105 22.4
80–84 30 27.3 38 21.1 68 23.4 27 24.5 39 21.7 66 22.8
85 and over 17 24.9 33 21.2 50 22.3 19 27.8 33 21.2 52 23.2
Total 702  560  1,262  573  445  1,018  
      
Crude rate 7.5 6.0 6.7 6.1 4.7 5.4
95% CI 7.0 – 8.1 5.5 – 6.4 6.4 – 7.1 5.6 – 6.7 4.3 – 5.2 5.1 – 5.8
AS rate (Aust 1991) 7.4 5.4 6.4 6.1 4.2 5.1
95% CI 6.9 – 8.0 5.0 – 5.9 6.0 – 6.8 5.6 – 6.6 3.8 – 4.6 4.8 – 5.4
AS rate (World) 6.3 4.7 5.5 4.9 3.4 4.1
95% CI 5.8 – 6.8 4.3 – 5.2 5.2 – 5.8 4.5 – 5.3 3.1 – 3.8 3.9 – 4.4
Lifetime risk (0–74) 1 in 157 1 in 222 1 in 184 1 in 186 1 in 271 1 in 221
PYLL (0–74)    9,370 7,033 16,403
Per cent of all 
cancers 1.6 1.5 1.6 3.0 3.0 3.0
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 239 7.7 174 5.1 413 6.3 196 6.3 144 4.1 340 5.1
Vic 184 8.1 143 5.7 327 6.8 143 6.3 115 4.4 258 5.3
Qld 130 8.0 92 5.3 222 6.6 106 6.6 73 4.2 179 5.3
WA 58 7.0 43 4.8 101 5.8 52 6.4 35 3.9 87 5.1
SA 63 8.2 47 5.7 111 6.9 49 6.3 38 4.4 87 5.2
Tas 19 7.9 13 5.2 32 6.5 17 7.0 11 4.3 28 5.5
ACT 12 10.0 6 4.2 18 6.8 9 8.0 8 5.7 17 6.7
NT 4 4.1 3 6.8 7 5.4 2 2.4 2 4.8 4 3.6
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 24: Cancers of unknown primary site (ICD-9 195–199)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 2 0.3 2 0.3 4 0.3 1 0.2 0 0.0 1 0.1
5–9 0 0.0 0 0.0 0 0.0 1 0.1 0 0.0 1 0.1
10–14 0 0.0 1 0.2 1 0.1 0 0.0 1 0.2 1 0.1
15–19 1 0.1 3 0.5 4 0.3 0 0.0 0 0.0 0 0.0
20–24 3 0.4 3 0.5 6 0.4 0 0.0 1 0.2 1 0.1
25–29 6 0.8 3 0.4 9 0.6 1 0.1 0 0.0 1 0.1
30–34 7 1.0 5 0.7 12 0.9 11 1.6 4 0.6 15 1.1
35–39 12 1.6 13 1.7 25 1.7 5 0.7 10 1.3 15 1.0
40–44 33 4.7 30 4.3 63 4.5 18 2.6 9 1.3 27 1.9
45–49 53 8.1 55 8.5 108 8.3 37 5.6 39 6.0 76 5.8
50–54 82 13.9 72 12.6 154 13.3 46 7.8 35 6.1 81 7.0
55–59 116 26.0 92 21.3 208 23.7 76 17.0 67 15.5 143 16.3
60–64 162 43.9 115 31.1 277 37.5 110 29.8 73 19.7 183 24.8
65–69 243 72.7 147 42.2 390 57.1 179 53.5 105 30.1 284 41.6
70–74 310 108.4 222 67.3 532 86.4 219 76.6 141 42.7 360 58.4
75–79 257 128.2 267 99.7 524 111.9 211 105.2 188 70.2 399 85.2
80–84 197 179.0 235 130.6 432 148.9 149 135.4 182 101.1 331 114.1
85 and over 145 212.3 273 175.0 418 186.4 134 196.2 247 158.3 381 169.9
Total 1,629  1,538  3,167  1,198  1,102  2,300  
      
Crude rate 17.5 16.3 16.9 12.9 11.7 12.3
95% CI 16.6 – 18.3 15.5 – 17.2 16.3 – 17.5 12.1 – 13.6 11.0 – 12.4 11.8 – 12.8
AS rate (Aust 1991) 18.0 13.1 15.3 13.3 9.2 11.0
95% CI 17.1 – 18.9 12.5 – 13.8 14.8 – 15.8 12.6 – 14.1 8.6 – 9.7 10.6 – 11.5
AS rate (World) 12.2 8.9 10.4 8.8 6.1 7.3
95% CI 11.5 – 12.8 8.4 – 9.4 10.0 – 10.8 8.3 – 9.3 5.7 – 6.5 7.0 – 7.6
Lifetime risk (0–74) 1 in 71 1 in 105 1 in 86 1 in 103 1 in 162 1 in 127
PYLL (0–74)    8,075 6,038 14,113
Per cent of all 
cancers 3.7 4.1 3.9 6.2 7.4 6.7
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 576 19.3 513 13.0 1,089 15.7 418 14.1 379 9.4 797 11.5
Vic 365 16.7 369 12.6 733 14.5 271 12.5 273 9.1 544 10.6
Qld 297 19.6 238 12.8 535 15.9 208 13.9 172 9.1 380 11.3
WA 144 19.2 116 12.1 259 15.3 98 13.4 90 9.3 188 11.1
SA 134 17.4 131 12.7 265 14.8 119 15.5 106 10.0 225 12.4
Tas 45 19.3 47 15.4 91 17.0 34 14.8 36 11.8 70 13.0
ACT 19 18.9 14 11.2 33 14.9 14 15.5 13 10.6 27 12.8
NT 11 24.6 7 17.5 18 21.5 8 20.2 5 15.4 13 17.9
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 25: Non-Hodgkin’s lymphoma (ICD-9 200+202)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 12 1.8 3 0.5 15 1.2 1 0.2 0 0.0 1 0.1
5–9 7 1.0 3 0.5 10 0.8 2 0.3 1 0.2 3 0.2
10–14 11 1.6 1 0.2 12 0.9 2 0.3 0 0.0 2 0.2
15–19 22 3.3 4 0.6 26 2.0 2 0.3 2 0.3 4 0.3
20–24 20 2.9 7 1.1 27 2.0 7 1.0 0 0.0 7 0.5
25–29 26 3.5 13 1.8 39 2.7 4 0.5 4 0.5 8 0.5
30–34 33 4.7 35 5.0 68 4.8 5 0.7 4 0.6 9 0.6
35–39 80 10.7 47 6.3 127 8.5 5 0.7 8 1.1 13 0.9
40–44 77 11.0 50 7.1 127 9.1 27 3.9 11 1.6 38 2.7
45–49 98 15.0 88 13.5 186 14.3 27 4.1 21 3.2 48 3.7
50–54 144 24.4 110 19.3 254 21.9 44 7.4 43 7.5 87 7.5
55–59 140 31.4 104 24.1 244 27.8 54 12.1 37 8.6 91 10.4
60–64 176 47.7 132 35.7 308 41.7 68 18.4 54 14.6 122 16.5
65–69 233 69.7 169 48.5 402 58.9 100 29.9 85 24.4 185 27.1
70–74 239 83.6 196 59.4 435 70.6 110 38.5 126 38.2 236 38.3
75–79 213 106.2 210 78.4 423 90.3 138 68.8 132 49.3 270 57.6
80–84 128 116.3 166 92.2 294 101.4 90 81.8 117 65.0 207 71.4
85 and over 83 121.5 128 82.0 211 94.1 64 93.7 114 73.1 178 79.4
Total 1,742  1,466  3,208  750  759  1,509  
      
Crude rate 18.7 15.6 17.1 8.0 8.1 8.1
95% CI 17.8 – 19.6 14.8 – 16.4 16.5 – 17.7 7.5 – 8.6 7.5 – 8.6 7.6 – 8.5
AS rate (Aust 1991) 18.7 13.4 15.9 8.3 6.6 7.3
95% CI 17.9 – 19.6 12.7 – 14.1 15.3 – 16.5 7.7 – 8.9 6.1 – 7.0 6.9 – 7.7
AS rate (World) 14.2 10.0 12.0 5.6 4.5 5.0
95% CI 13.5 – 14.8 9.4 – 10.5 11.5 – 12.4 5.2 – 6.0 4.1 – 4.8 4.7 – 5.3
Lifetime risk (0–74) 1 in 65 1 in 90 1 in 75 1 in 170 1 in 199 1 in 183
PYLL (0–74)    6,835 5,020 11,855
Per cent of all 
cancers 4.0 3.9 4.0 3.9 5.1 4.4
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 580 18.8 487 13.3 1,067 15.8 263 8.7 246 6.3 508 7.4
Vic 437 19.5 371 13.8 808 16.4 215 9.8 194 6.8 409 8.1
Qld 278 17.6 220 12.3 498 14.8 121 7.9 108 5.8 229 6.8
WA 133 16.6 107 11.9 240 14.1 59 7.8 55 6.0 114 6.7
SA 141 18.3 140 15.1 281 16.5 69 9.0 65 6.4 134 7.6
Tas 42 17.7 40 14.5 82 15.9 20 8.4 21 7.3 41 7.7
ACT 21 18.8 20 15.9 41 17.0 11 12.1 10 8.6 21 10.0
NT 7 12.4 5 10.2 12 11.4 1 1.0 1 3.7 2 2.3
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 26: Leukaemias (ICD-9 204–208)
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 51 7.7 45 7.2 96 7.5 15 2.3 5 0.8 20 1.6
5–9 35 5.2 27 4.2 62 4.7 9 1.3 12 1.9 21 1.6
10–14 15 2.2 18 2.8 33 2.5 16 2.4 9 1.4 25 1.9
15–19 28 4.2 10 1.6 38 2.9 13 1.9 14 2.2 27 2.1
20–24 20 2.9 11 1.7 31 2.3 9 1.3 7 1.1 16 1.2
25–29 13 1.8 16 2.2 29 2.0 6 0.8 7 1.0 13 0.9
30–34 32 4.5 19 2.7 51 3.6 11 1.6 11 1.6 22 1.6
35–39 17 2.3 30 4.0 47 3.1 15 2.0 12 1.6 27 1.8
40–44 36 5.2 19 2.7 55 3.9 11 1.6 10 1.4 21 1.5
45–49 51 7.8 22 3.4 73 5.6 13 2.0 11 1.7 24 1.8
50–54 79 13.4 50 8.8 129 11.1 33 5.6 18 3.2 51 4.4
55–59 69 15.5 55 12.8 124 14.1 43 9.6 26 6.0 69 7.9
60–64 103 27.9 54 14.6 157 21.2 61 16.5 29 7.8 90 12.2
65–69 142 42.5 78 22.4 220 32.2 87 26.0 49 14.1 136 19.9
70–74 182 63.6 102 30.9 284 46.1 130 45.5 58 17.6 188 30.5
75–79 163 81.3 120 44.8 283 60.4 135 67.3 85 31.7 220 47.0
80–84 94 85.4 111 61.7 205 70.7 81 73.6 82 45.6 163 56.2
85 and over 79 115.7 110 70.5 189 84.3 80 117.1 105 67.3 185 82.5
Total 1,209  897  2,106  768  550  1,318  
      
Crude rate 13.0 9.5 11.2 8.2 5.8 7.0
95% CI 12.2 – 13.7 8.9 – 10.2 10.8 – 11.7 7.7 – 8.8 5.4 – 6.3 6.7 – 7.4
AS rate (Aust 1991) 13.2 8.2 10.5 8.5 4.8 6.5
95% CI 12.5 – 14.0 7.7 – 8.8 10.1 – 11.0 7.9 – 9.1 4.4 – 5.2 6.1 – 6.8
AS rate (World) 10.3 6.7 8.4 6.0 3.5 4.7
95% CI 9.7 – 11.0 6.2 – 7.2 8.0 – 8.8 5.6 – 6.5 3.2 – 3.8 4.4 – 4.9
Lifetime risk (0–74) 1 in 97 1 in 165 1 in 123 1 in 167 1 in 317 1 in 221
PYLL (0–74)    9,180 6,520 15,700
Per cent of all 
cancers 2.8 2.4 2.6 4.0 3.7 3.8
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 406 13.4 300 8.2 706 10.5 249 8.4 186 4.9 435 6.4
Vic 275 12.6 218 8.0 493 10.0 179 8.2 138 4.8 316 6.3
Qld 237 15.3 176 9.8 414 12.4 137 9.1 94 5.0 231 6.9
WA 91 11.6 67 7.3 157 9.2 60 7.9 42 4.5 102 6.0
SA 132 17.2 98 10.6 231 13.5 77 10.2 53 5.3 130 7.4
Tas 27 11.4 24 8.6 50 9.7 15 6.6 14 4.6 29 5.4
ACT 12 11.0 12 9.1 25 9.9 12 11.5 8 6.0 20 8.5
NT 4 5.2 5 9.4 9 7.2 2 3.1 3 7.0 5 5.0
Note:  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 27: Alcohol-related cancers
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
5–9 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
10–14 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
15–19 0 0.0 0 0.1 1 0.0 0 0.0 0 0.0 0 0.0
20–24 1 0.1 1 0.1 2 0.1 0 0.0 0 0.0 0 0.0
25–29 3 0.5 2 0.3 5 0.4 1 0.1 1 0.1 1 0.1
30–34 3 0.5 5 0.7 8 0.6 1 0.2 1 0.1 2 0.1
35–39 5 0.7 10 1.3 15 1.0 2 0.3 2 0.3 4 0.3
40–44 20 2.8 27 3.9 47 3.4 8 1.1 4 0.6 12 0.9
45–49 29 4.4 39 5.9 67 5.1 10 1.6 7 1.2 18 1.4
50–54 49 8.4 51 8.9 100 8.6 24 4.1 11 1.9 35 3.0
55–59 56 12.5 44 10.2 99 11.3 26 5.9 9 2.2 36 4.1
60–64 68 18.4 42 11.3 110 14.8 41 11.0 11 3.1 52 7.0
65–69 62 18.6 45 12.9 107 15.7 39 11.8 14 3.9 53 7.8
70–74 51 17.7 46 13.9 96 15.7 35 12.2 17 5.1 52 8.4
75–79 19 9.6 13 4.9 32 6.9 14 7.1 7 2.7 22 4.6
80–84 6 5.5 9 4.8 15 5.0 5 4.7 6 3.1 11 3.7
85 and over 3 4.4 7 4.7 10 4.6 3 4.3 6 4.0 9 4.1
Total 376  339  715  210  96  307  
      
Crude rate 4.0 3.6 3.8 2.3 1.0 1.6
95% CI 3.6 – 4.4 3.2 – 4.0 3.5 – 4.1 2.0 – 2.6 0.8 – 1.2 1.5 – 1.8
AS rate (Aust 1991) 3.9 3.3 3.6 2.2 0.9 1.5
95% CI 3.5 – 4.3 2.9 – 3.7 3.3 – 3.9 1.9 – 2.5 0.7 – 1.1 1.4 – 1.7
AS rate (World) 3.3 2.8 3.0 1.8 0.7 1.2
95% CI 2.9 – 3.6 2.5 – 3.1 2.8 – 3.3 1.5 – 2.0 0.6 – 0.9 1.1 – 1.4
Lifetime risk (0–74) 1 in 237 1 in 289 1 in 261 1 in 415 1 in 1,088 1 in 606
PYLL (0–74)    2,603 1,191 3,794
Per cent of all 
cancers 0.9 0.9 0.9 1.1 0.6 0.9
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 126 3.9 111 3.2 237 3.6 72 2.3 34 1.0 106 1.6
Vic 90 3.9 83 3.3 173 3.6 54 2.4 28 1.1 82 1.7
Qld 69 4.2 54 3.2 123 3.7 37 2.3 16 0.9 53 1.6
WA 32 3.8 29 3.3 61 3.5 19 2.3 9 1.0 28 1.6
SA 25 3.1 27 3.1 52 3.1 15 1.9 9 0.9 24 1.4
Tas 9 3.5 8 3.2 17 3.3 5 2.1 3 0.9 8 1.5
ACT 4 3.2 5 3.3 9 3.2 2 2.0 1 1.1 4 1.6
NT 5 8.7 2 2.9 7 6.1 2 4.6 0 1.3 3 3.1
Notes
1.  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
2.   Cancers attributable to alcohol are oropharynx, oesophagus, liver, larynx and female breast cancer.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Table 28: Smoking-related cancers
Australia 1998
Incidence Mortality
Males Females Persons Males Females Persons
Number Rate Number Rate Number Rate Number Rate Number Rate Number Rate
Age group
0–4 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
5–9 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
10–14 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
15–19 7 1.1 2 0.4 10 0.7 1 0.2 1 0.1 2 0.2
20–24 31 4.5 8 1.2 39 2.8 2 0.3 1 0.1 3 0.2
25–29 51 6.9 21 2.9 72 4.9 4 0.6 3 0.4 7 0.5
30–34 69 9.8 43 6.0 112 7.9 9 1.3 6 0.9 16 1.1
35–39 113 15.2 61 8.1 174 11.7 22 3.0 14 1.8 36 2.4
40–44 195 27.9 82 11.7 277 19.8 58 8.3 31 4.4 89 6.3
45–49 289 44.1 129 19.8 418 32.0 127 19.3 59 9.1 186 14.2
50–54 513 86.8 180 31.6 693 59.7 260 43.9 116 20.4 376 32.4
55–59 657 147.3 224 52.0 881 100.5 393 88.0 149 34.5 541 61.7
60–64 961 260.4 288 77.7 1,248 168.9 624 169.1 182 49.3 806 109.1
65–69 1,333 398.6 406 116.3 1,738 254.5 905 270.6 261 74.9 1,166 170.7
70–74 1,517 530.6 505 152.9 2,022 328.3 1,116 390.1 355 107.6 1,471 238.8
75–79 1,141 569.2 397 148.1 1,538 328.4 887 442.3 298 111.3 1,185 253.0
80–84 587 533.4 180 100.1 767 264.5 545 495.2 158 88.0 704 242.5
85 and over 393 574.9 124 79.4 517 230.3 363 530.9 119 76.3 482 214.7
Total 7,857  2,649  10,506  5,314  1,754  7,068  
      
Crude rate 84.3 28.2 56.1 57.0 18.6 37.7
95% CI 82.4 – 86.2 27.1 – 29.2 55.0 – 57.2 55.5 – 58.6 17.8 – 19.5 36.9 – 38.6
AS rate (Aust 1991) 85.3 25.0 52.4 58.5 16.1 35.0
95% CI 83.4 – 87.2 24.0 – 25.9 51.4 – 53.4 56.9 – 60.0 15.3 – 16.9 34.1 – 35.8
AS rate (World) 61.3 18.8 38.7 40.0 11.7 24.7
95% CI 59.9 – 62.7 18.0 – 19.6 37.9 – 39.5 38.8 – 41.1 11.1 – 12.3 24.1 – 25.3
Lifetime risk (0–74) 1 in 14 1 in 42 1 in 21 1 in 21 1 in 66 1 in 32
PYLL (0–74)    37,043 13,983 51,026
Per cent of all 
cancers 18.0 7.1 13.0 27.4 11.8 20.6
Average annual numbers and rates by State and Territory 1994–1998
Incidence Mortality
Males Females Persons Males Females Persons
Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate Number AS rate
NSW 2,561 83.6 884 24.7 3,446 51.2 1,778 58.8 604 16.4 2,383 35.0
Vic 1,991 89.5 668 25.3 2,659 54.1 1,358 61.8 467 17.2 1,825 36.8
Qld 1,501 96.6 452 26.1 1,954 58.9 951 62.5 278 15.9 1,230 37.1
WA 641 83.5 225 25.5 867 51.9 453 60.6 152 17.1 605 36.5
SA 651 83.3 206 22.4 857 49.6 456 58.4 141 14.8 596 33.9
Tas 235 98.9 77 28.5 313 60.4 157 66.5 50 18.0 207 39.4
ACT 67 64.4 30 24.3 97 42.1 54 56.1 22 17.7 76 34.3
NT 53 110.4 18 42.2 71 78.9 35 90.2 12 28.3 47 60.2
Notes
1.  AS rates use Australian 1991 Standard Population unless World Standard Population is indicated. All rates are expressed per 100,000 population.
2.  Cancers attributable to smoking are oropharynx, oesophagus, stomach, anus, pancreas, larynx, lung, uterus, cervix, vulva, penis, bladder, renal parenchyma
      and renal pelvis.
Source: Cancer in Australia 1998, AIHW & AACR 2001.
Rates per 100,000 with 95 per cent confidence intervals (95% CI)
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Appendix A: International Classification of Diseases,
Ninth Revision—cancer site—codes and
combinations
Buccal cavity
Lip 140
Tongue 141
Salivary glands 142
Gum 143
Floor of mouth 144
Other and unspecified parts of mouth 145
Pharynx
Oropharynx 146
Nasopharynx 147
Hypopharynx 148
Other sites within the lip, oral cavity and
pharynx
149
Head and neck 141–149
Digestive organs and peritoneum
Oesophagus 150
Stomach 151
Small intestine 152
Colon 153
Rectum 154
Colorectal 153–154
Liver and intrahepatic bile ducts 155
Gallbladder and extrahepatic bile ducts 156
Pancreas 157
Retroperitoneum and peritoneum 158
Unspecified digestive organs 159
Respiratory system
Nasal cavities, middle ear and
accessory sinuses
160
Larynx 161
Trachea, bronchus and lung 162
Pleura 163
Respiratory systems, ill-defined and
other intrathoracic organs 164–165
Bone, connective tissue, skin and breast
Bone and articular cartilage 170
Connective and other soft tissue 171
Melanoma 172
Non-melanocytic skin cancer (NMSC) 173
Breast 174–175
Genitourinary organs
Cervix 180
Placenta 181
Corpus uteri 179+182
Ovary and other uterine adnexae 183
Other and unspecified female
genital organs 184
Prostate 185
Testis 186
Penis and other male genital organs 187
Bladder 188
Kidney, ureter and urethra 189
Gynaecological cancers 179–180, 182–184
Other and unspecified organs
Eye 190
Brain 191
Other and unspecified parts of the
nervous system (NS)
192
Thyroid gland 193
Other endocrine glands 194
Unknown primary site 195–199
Lymphatic and haematopoietic tissue
Non-Hodgkin’s lymphomas (NHL) 200+202
Lymphosarcoma and reticulosarcoma 200
Hodgkin’s disease 201
Other neoplasms of lymphoid and
histiocytic tissue 202
Lymphomas 200–202
Multiple myeloma and
immunoproliferative neoplasms 203
Lymphatic leukaemia 204
Acute lymphatic leukaemia 204.0
Chronic lymphatic leukaemia 204.1
Myeloid leukaemia 205
Acute myeloid leukaemia 205.0
Chronic myeloid leukaemia 205.1
Monocytic leukaemia 206
Other and unspecified leukaemias 207–208
Leukaemias 204–208
Smoking-related cancers (aetiological
fractions are applied to the following
codes)
140, 141,
143–151,
154.3–154.4, 157,
161, 162, 180,
179+182, 184.4,
186, 188, 189.0,
189.1
Alcohol-related cancers (aetiological
fractions are applied to the following
codes)
141, 143–146,
148–149, 150,
155, 161, 174
Note: Abbreviated versions of these names may be used
in this report.
Source: World Health Organization 1977.
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Appendix B: Methods
This section describes the methods used to calculate the estimates presented in the tables in
this report. The calculations in the example below are applicable to both incidence and
mortality.
Example table
Trachea, bronchus and lung cancer incidence (ICD 162)—males
No. of cases
Australian
1998 male
population*
Age-specific rate
per 100,000
population
Australian 1991
Population
Standard**
Expected number
of cases
Age group column 1 column 2 column 3 column 4 column 5
0–4 1 658,557 0.2 1,271,703 2.5
5–9 0 679,115 0.0 1,272,208 0.0
10–14 0 671,916 0.0 1,241,619 0.0
15–19 0 674,294 0.0 1,364,074 0.0
20–24 3 691,414 0.4 1,396,764 5.6
25–29 1 737,171 0.1 1,399,663 1.4
30–34 5 703,307 0.7 1,425,735 10.0
35–39 24 745,555 3.2 1,328,387 42.5
40–44 58 698,248 8.3 1,294,271 107.4
45–49 113 654,875 17.3 1,029,145 178.0
50–54 267 591,213 45.2 846,934 382.8
55–59 379 446,092 85.0 725,950 617.1
60–64 667 368,937 180.8 736,868 1,332.3
65–69 978 334,283 292.6 671,390 1,964.5
70–74 1,156 286,022 404.2 510,755 2,064.5
75–79 922 200,522 459.8 384,495 1,767.9
80–84 440 110,080 399.7 229,828 918.6
85+ 293 68,296 429.0 154,247 661.7
Total 5,307 9,319,897 56.9 17,284,036 58.2
* Australian Bureau of Statistics 2000.
** Australian Bureau of Statistics 1993.
Crude rates—all age groups
A crude incidence rate is defined as the number of new cases of cancer divided by the
population at risk in a specified time period. A crude mortality rate substitutes deaths for
new cases in this calculation. Both are conventionally expressed as annual rates per 100,000
population and may be calculated for males, females or persons, or for subsets of the
population (for example, see age-specific rates). The total rate calculated in this way without
adjustment for age or other factors is known as the ‘crude rate’.
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The crude rate is calculated by dividing the total number of cases across all age groups by
the total population, for example
Column 1 total
[ 100,000Crude incidence rate for lung cancer =
5,307
9,319,897
=
=  56.9 per 100,000
Column 2 total
[ 100,000
Age-specific rates
Age-specific rates are calculated by dividing the number of cases occurring in each specified
age group by the corresponding population in the same age group expressed as a rate per
100,000 population. This rate may be calculated for particular age and sex groupings, for
example
Column 1 for this age
[ 100,000
Age-specific lung
cancer incidence
rates in males
aged 75–79
=
922
200,522
=
=  459.8 per 100,000
Column 2 for this age
[ 100,000
Age-standardised rates (AS rate)
Rates are adjusted for age to facilitate comparisons between populations which have
different age structures, for example between youthful and aging communities. There are
two different methods commonly used to adjust for age. In this publication direct
standardisation is used, in which age-specific rates are multiplied against a constant
population (the Australian 1991 Population Standard or the World Standard Population).
This effectively removes the influence of age structure on the summary rate which is
described as the age-standardised rate. The method may be used for both incidence and
mortality calculations. The method used for this calculation comprises three steps which can
be followed by reference to the example table on the previous page.
Step 1 Calculate the age-specific rate (as shown above) for each age group (column 3).
Step 2 Calculate the expected number of cases in each 5-year age group by multiplying
the age-specific rates (column 3) by the corresponding standard population
(column 4) and dividing by 100,000, giving you the expected number of cases
(column 5).
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Step 3 To give the age-standardised rate, sum the expected number of cases in each age
group (total column 5). Divide this sum by the total of the standard population
used in the calculation and multiply by 100,000.
Confidence intervals (Cl)
The age-standardised and crude incidence and mortality rates presented in the body of this
report also show 95% confidence intervals. These confidence intervals indicate the variation
that might be expected in such estimates purely by chance. The confidence intervals are
calculated using the methods presented in Holman et al. (1987).
A relatively simple approximation of the confidence limits that readers might use when
examining State and Territory age-standardised rates is as set out below.
95% CI approximation = AS rate  1.96 [
AS
 
rate
Number of cases
Lifetime risk and cumulative rate
Lifetime risk is a measure which approximates the risk of contracting a particular cancer in a
lifetime if the risks at the time of estimation remained throughout life. It is based on a
mathematical relationship with the cumulative rate and is calculated in this publication for
ages 0–74.
Cumulative rate is a directly standardised rate calculated by summing age-specific rates
from equal age groups, for example 5–9, 10–14 years. An example is provided below.
5 [ (Sum of the age-specific rates) [ 100
100,000
Cumulative rate =
5 [ 1,038 [ 100
100,000
=
=  5.19%
The factor of 5 is used to indicate the 5 years of life in each age group and the factor of 100 is
used to present the result as a percentage. As age-specific rates are presented per 100,000
population (column 3), the result is divided by 100,000 to return the age-specific rates to a
division of cases by population. Cumulative risk is related to cumulative rate by the
expression:
1
−
e− rate 100( )Cumulative risk      =
where rate is expressed as a percentage.
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Lifetime risk is expressed as a ‘1 in n’ proportion by taking the inverse of the above formula:
1
1
−
e−rate  100(  )n      =
For lung cancer in men, the cumulative rate was 5.19% (see previous page), therefore:
1
1
−
e − 5.19 100( )n    =
=       19.75
That is, for men, the lifetime risk (0–74 years) of developing lung cancer is 1 in 20, providing
they remain at risk for the whole period and the 1998 age-specific rates apply throughout
their lives. Note that no account has been taken of specific cancer risk factors, for example
the risk for men who smoke would be higher than that for those who have never smoked.
Per cent of all cancers
The ‘per cent of all cancers’ measure is the proportion of all causes accounted for by a
particular cancer. The measure may be computed for cancer incidence or mortality. Using an
incidence example, the measure is calculated by taking the number of new cases of a
particular cancer, for example lung cancer, and dividing that by the total number of all new
cancer cases and multiplying by 100 to express it as a percentage. This is undertaken for each
sex and for total persons. Note that for this publication the incidence and mortality of non-
melanocytic skin cancers is not included in total new cancer cases.
Sex ratio
This measure indicates the relative incidence or mortality between the sexes. It can be
calculated on the basis of observed numbers, crude rates, age-standardised rates or
cumulative rates per cent. In this publication it is calculated using the age-standardised rates
where the male rate is divided by the female rate for each cancer. Ratios greater than 1
indicate an excess in males while ratios less than 1 indicate an excess in females.
It is preferable to use either the age-standardised rates or the cumulative rate as these both
adjust for age variations between male and female populations. In addition, the use of
cumulative rate per cent discounts the occurrence of cancer in people aged over 75. This
gives more emphasis, therefore, to early cancer diagnosis or death, and diminishes the
impact of variable diagnostic investigation of the elderly.
Person-years of life lost
Person-years of life lost is a concept which attempts to measure the number of years of life
lost per annum due to death as a result of a specific cause, for example lung cancer, given
life expectancies at specific ages. Age groups 0–4 up to 70–74 were used for the calculations,
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as deaths before age 75 are regarded as premature for both men and women. The method
used in this publication for the calculation of person-years of life lost is an aggregation of
years between age at death and 75 for each person for each cancer, for example a person
dying at age 50 contributes 25 years to the measure of person-years of life lost.
Average annual rates of change
To indicate the extent of change in age-standardised rates over time, a linear line of best fit is
calculated for the time frame in question. Average annual rates of change are then calculated
using the geometric formula:
Average rate of change = ( )( )1/ /1 −Non PP  x 100
where nP = rate at later year n
oP = rate at earlier year o
N = on − .
This process averages out variations in the actual annual changes that may have occurred
between the two points in time.
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Appendix C: Population data
Australian resident population 1998
1998
Age Males Females Total
0–4 658,557 624,234 1,282,791
5–9 679,115 645,215 1,324,330
10–14 671,916 640,736 1,312,652
15–19 674,294 639,297 1,313,591
20–24 691,414 665,691 1,357,105
25–29 737,171 733,145 1,470,316
30–34 703,307 706,925 1,410,232
35–39 745,555 748,913 1,494,468
40–44 698,248 702,629 1,400,877
45–49 654,875 649,539 1,304,414
50–54 591,213 570,287 1,161,500
55–59 446,092 431,183 877,275
60–64 368,937 370,123 739,060
65–69 334,283 348,707 682,990
70–74 286,022 329,909 615,931
75–79 200,522 267,923 468,445
80–84 110,080 180,000 290,080
85+ 68,296 156,006 224,302
Total 9,319,897 9,410,462 18,730,359
Source: Australian Bureau of Statistics 2000.
Australian Standard Population and World Standard Population
Australian Standard Population* (1991) World Standard Population**(1966)
Age % of total % of total
0–4 1,271,703 7.4 12,000 12.0
5–9 1,272,208 7.4 10,000 10.0
10–14 1,241,619 7.2 9,000 9.0
15–19 1,364,074 7.9 9,000 9.0
20–24 1,396,764 8.1 8,000 8.0
25–29 1,399,663 8.1 8,000 8.0
30–34 1,425,735 8.2 6,000 6.0
35–39 1,328,387 7.7 6,000 6.0
40–44 1,294,271 7.5 6,000 6.0
45–49 1,029,145 6.0 6,000 6.0
50–54 846,934 4.9 5,000 5.0
55–59 725,950 4.2 4,000 4.0
60–64 736,868 4.3 4,000 4.0
65–69 671,390 3.9 3,000 3.0
70–74 510,755 3.0 2,000 2.0
75–79 384,495 2.2 1,000 1.0
80–84 229,828 1.3 500 0.5
85+ 154,247 0.9 500 0.5
Total 17,284,036 100.0 100,000 100.0
* Australian Bureau of Statistics 1993.
** Doll et al. 1966.
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Appendix D: Cancer registration in Australia
The table below provides information about cancer registration in Australia. Each State and
Territory operates its own registry. Generally, operational guidelines for each of the
registries are similar and coincide with the objectives of the International Association of
Cancer Registries. Although some registries operate under different coding systems for site,
morphology and other variables, the bulk of information is directly comparable and has
been reconciled for this publication. The reporting sources of the registries vary according to
the local conditions and those bodies named in the legislation. Every attempt is made to
report all cancer cases, although not every case will be identified. Cancer registries are
dependent upon their reporting sources. Variation in reporting of cancers by age, sex, type,
geographical location, country of birth or other variables does occur and may have effects on
the final statistics. Occasionally, delays in reporting some case information may extend over
several years but this has a minimal effect on the final reported data. In order to minimise
the effects on the final reported registration, multiple reporting sources are used to compile
case information where possible. Case information is exchanged between registries where
there is cause for suspicion of duplicate registration. Further information regarding registry
coding practices may be obtained by contacting the Registrar in each State or Territory.
States and Territories NSW Vic Qld WA SA Tas ACT NT
Total population (1998) 6,333,515 4,654,937 3,453,477 1,829,145 1,486,418 471,700 308,057 189,937
Per cent of Australian
population 33.8 24.9 18.4 9.8 7.9 2.5 1.6 1.0
Per cent of population
older than age 65 12.7 12.6 11.3 10.5 14.2 13.1 7.8 3.3
No. new cancers
(1994–1998)** 27,072 20,113 14,546 6,741 7,074 2,203 964 366
First year of population
registration 1972 1982 1982 1982 1977 1978 1972 1981
Year of legislation 1972 1982 1982 1981 1977 1992 1994 1991
Funding source Pvte–Govt Pvte–Govt Govt Govt Govt Pvte–Govt Govt Govt
ICD site coding ICD-O-2 ICD-9 ICD-9 ICD-O-2 ICD-9 ICD-9 ICD-O-2 ICD-9
Morphology coding ICD-O-2 ICD-O-2 ICD-O-2 ICD-O-2 SNOMED-II ICD-O-2 ICD-O-2 SNOMED-II
Reporting sources
Public hospitals Yes Yes Yes No* Yes Yes Yes Yes
Private hospitals Yes Yes Yes No* Yes Yes Yes No
Repatriation hospitals Yes Yes Yes No* Yes Yes Yes No
Pathology laboratories Yes Yes Yes Yes Yes Yes Yes Yes
Radiotherapy units Yes Yes Yes Yes Yes Yes Yes No
Nursing homes Yes No Yes No No No* Yes No
Registrar of Births,
Deaths and Marriages Yes Yes Yes Yes Yes Yes Yes Yes
Doctors No* No* No* No* No* No* No* No*
* Data are provided on special request only.
** Refers to the average number of new cases over the 5-year period 1994–1998.
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Appendix E: Cancer registries contact list
NSW Central Cancer Registry
NSW Cancer Council
LMB 1
KINGS CROSS NSW 1340
Phone: +61 2 9334 1902
Fax: +61 2 9368 0843
E-mail: ccr@nswcc.org.au
Home page: www.nswcc.org.au
Director: Professor Bruce Armstrong
E-mail: brucea@nswcc.org.au
Phone: +61 2 9334 1837
Registry Manager: Ms Elizabeth Tracey
E-mail: etracey@nswcc.org.au
Phone: +61 2 9334 1974
Victorian Cancer Registry
Anti-Cancer Council of Victoria
1 Rathdowne Street
CARLTON SOUTH VIC 3053
Phone: +61 3 9635 5000
Fax: +61 3 9635 5210
Home page: www.accv.org.au
Director: Professor Graham Giles
E-mail: ggg@accv.org.au
Phone: +61 3 9635 5154
Director Information Systems:
Ms Helen Farrugia
E-mail: helenf@accv.org.au
Phone: +61 3 9635 5318
Statistician: Mrs Vicky Thursfield
E-mail: vickyt@accv.org.au
Phone: +61 3 9635 5162
Queensland Cancer Registry
Locked Bag 1450
SPRING HILL POST OFFICE QLD 4004
Phone: +61 7 3258 2331
Fax: +61 7 3258 2345
Director: Dr Ian Ring
E-mail: ian_ring@health.qld.gov.au
Phone: +61 7 3234 0921
Fax: +61 7 3234 1529
Registrar: Mrs Judy Symmons
E-mail: judith_symmons@health.qld.gov.au
Phone: +61 7 3258 2333
Fax: +61 7 3258 2345
Western Australian Cancer Registry
Health Information Centre
Health Department of Western Australia
PO Box 8172
Stirling Street
PERTH WA 6849
Phone: +61 8 9222 4022/4249
Fax: +61 8 9222 4236
E-mail: wacanreg@health.wa.gov.au
Home page: www.health.wa.gov.au
Director & Registrar: Dr Tim Threlfall
E-mail: tim.threlfall@health.wa.gov.au
South Australian Cancer Registry
Epidemiology Branch, Dept of Human Services
PO Box 6
RUNDLE MALL SA 5000
Phone: +61 8 8226 6372
Fax: +61 8 8226 6291
Home page: www.dhs.sa.gov.au/pehs/
disease-control-status.htm
Director: Dr Colin Luke
E-mail: Colin.Luke@dhs.sa.gov.au
Phone: +61 8 8226 6360
Registrar: Ms Lesley Milliken
E-mail: Lesley.Milliken@dhs.sa.gov.au
Phone: +61 8 8226 6372
Medical Officer (Public Health Physician):
Dr Wayne Clapton
E-mail: Wayne.Clapton@dhs.sa.gov.au
Phone: +61 8 8226 6362
Tasmanian Cancer Registry
Menzies Centre for Population Health
Research
GPO Box 252-23
HOBART TAS 7001
Phone: +61 3 6226 7706
Fax: +61 3 6226 7704
Director: Dr Alison Venn
E-mail: Alison.Venn@utas.edu.au
Phone: +61 3 6226 7706
Registrar: Shevaun Pavlides
E-mail: shevaun.pavlides@utas.edu.au
Phone: +61 3 6226 7714
Fax: +61 3 6226 7704
77
Northern Territory Cancer Registry
Epidemiology & Statistics Branch
Territory Health Services
PO Box 40596
CASUARINA NT 0811
Phone: +61 8 8999 2977
Fax: +61 8999 2618
Director & Registrar: Dr John Condon
E-mail: john.condon@nt.gov.au
Phone: +61 8 8999 2977
Fax: +61 8 8999 2600
Epidemiologist: Mr Michael Pearce
E-mail:
michael.pearce@dwnhhse.health.nt.gov.au
Phone: +61 8 8999 2540
New Zealand Cancer Registry
Clinical Coding Services
New Zealand Health Information Service
Level 6, WestpacTrust House
119–125 Willis Street
PO Box 5013
Wellington
New Zealand
Phone: +64 4 922 1800
Fax: +64 4 922 1897
Team Leader: Christine Fowler
E-mail: christine.fowler@nzhis.govt.nz
Phone: +64 4 922 1864
Chief Analyst: Jim Fraser
E-mail: jim.fraser@nzhis.govt.nz
Phone: +64 4 922 1862
Australian Capital Territory Cancer
Registry
ACT Cancer Registry
Clinical Epidemiology & Health Outcomes
Centre
Level 1, Building 5, The Canberra Hospital
PO Box 11
WODEN ACT 2606
Phone: +61 2 6244 4276
Fax: +61 2 6244 4138
Director: Dr Bruce Shadbolt
E-mail: bruce.shadbolt@act.gov.au
Phone: +61 2 6244 4288
Fax: +61 2 6244 4138
Registrar: Ms Barbara Stuart-Harris
E-mail: barbara.stuartharris@act.gov.au
Phone: +61 2 6244 4285
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Appendix F: Tables published on the Internet
Table 1: All cancers (except non-melanocytic skin cancers) (ICD-9 140–172, 174–208)
Table 2: Cancer of the lip (ICD-9 140)
Table 3: Cancer of the tongue (ICD-9 141)
Table 4: Cancer of the salivary gland (ICD-9 142)
Table 5: Cancer of the gum (ICD-9 143)
Table 6: Cancer of the floor of mouth (ICD-9 144)
Table 7: Cancer of other and unspecified parts of mouth (ICD-9 145)
Table 8: Cancer of the oropharynx (ICD-9 146)
Table 9: Cancer of the nasopharynx (ICD-9 147)
Table 10: Cancer of the hypopharynx (ICD-9 148)
Table 11: Cancer of other sites within the lip, oral cavity and pharynx (ICD-9 149)
Table 12: Cancer of the head and neck (ICD-9 141–149)
Table 13: Cancer of the oesophagus (ICD-9 150)
Table 14: Cancer of the stomach (ICD-9 151)
Table 15: Cancer of the small intestine (ICD-9 152)
Table 16: Cancer of the colon (ICD-9 153)
Table 17: Cancer of the rectum (ICD-9 154)
Table 18: Cancer of the colon and rectum (ICD-9 153–154)
Table 19: Cancer of the liver and intrahepatic bile ducts (ICD-9 155)
Table 20: Cancer of the gallbladder and extrahepatic bile ducts (ICD-9 156)
Table 21: Cancer of the pancreas (ICD-9 157)
Table 22: Cancer of the retroperitoneum and peritoneum (ICD-9 158)
Table 23: Cancer of the unspecified digestive organs (ICD-9 159)
Table 24: Cancer of the nasal cavities, middle ear and accessory sinuses (ICD-9 160)
Table 25: Cancer of the larynx (ICD-9 161)
Table 26: Cancer of the trachea, bronchus and lung (ICD-9 162)
Table 27: Cancer of the pleura (ICD-9 163)
Table 28: Cancer of the other respiratory organs (ICD-9 164–165)
Table 29: Cancer of the bone and articular cartilage (ICD-9 170)
Table 30: Cancer of the connective and other soft tissue (ICD-9 171)
Table 31: Cancer of the skin—melanoma (ICD-9 172)
Table 32: Cancer of the skin—non-melanocytic (ICD-9 173)
Table 33: Cancer of the breast (ICD-9 174–175)
Table 34: Cancer of the cervix (ICD-9 180)
Table 35: Cancer of the placenta (ICD-9 181)
Table 36: Cancer of the uterus (ICD-9 179+182)
Table 37: Cancer of the ovary and other uterine adnexae (ICD-9 183)
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Table 38: Cancer of the other and unspecified female genital organs (ICD-9 184)
Table 39: Gynaecological cancers (ICD-9 179–180, 182–184)
Table 40: Cancer of the prostate (ICD-9 185)
Table 41: Cancer of the testis (ICD-9 186)
Table 42: Cancer of the penis and other male genital organs (ICD-9 187)
Table 43: Cancer of the bladder (ICD-9 188)
Table 44: Cancer of the kidney and other and unspecified urinary organs (ICD-9 189)
Table 45: Cancer of the eye (ICD-9 190)
Table 46: Cancer of the brain (ICD-9 191)
Table 47: Cancers of other central nervous system (ICD-9 192)
Table 48: Cancers of the brain and nervous system (ICD-9 191–192)
Table 49: Cancer of the thyroid gland (ICD-9 193)
Table 50: Cancers of other endocrine glands (ICD-9 194)
Table 51: Cancers of unknown primary site (ICD-9 195–199)
Table 52: Lymphosarcoma and reticulosarcoma (ICD-9 200)
Table 53: Hodgkin’s disease (ICD-9 201)
Table 54: Lymphoid and histiocytic tissue (ICD-9 202)
Table 55: Non-Hodgkin’s lymphoma (ICD-9 200+202)
Table 56: Lymphomas (ICD-9 200–202)
Table 57: Multiple myeloma (ICD-9 203)
Table 58: Lymphatic leukaemia (ICD-9 204)
Table 59: Acute lymphatic leukaemia (ICD-9 204.0)
Table 60: Chronic lymphatic leukaemia (ICD-9 204.1)
Table 61: Myeloid leukaemia (ICD-9 205)
Table 62: Acute myeloid leukaemia (ICD-9 205.0)
Table 63: Chronic myeloid leukaemia (ICD-9 205.1)
Table 64: Monocytic leukaemia (ICD-9 206)
Table 65: Other specified leukaemia (ICD-9 207)
Table 66: Unspecified leukaemia (ICD-9 208)
Table 67: Other and unspecified leukaemia (ICD-9 207–208)
Table 68: Leukaemias (ICD-9 204–208)
Table 69: Alcohol-related cancers
Table 70: Smoking-related cancers
80
Glossary
AACR: Australasian Association of Cancer Registries.
ABS: Australian Bureau of Statistics.
ACT: Australian Capital Territory—a land-locked Territory of Australia situated within the
State of New South Wales on the eastern seaboard, with a population of 308,057 (1998). Its
capital city is Canberra, which is also Australia’s capital city.
AIHW: Australian Institute of Health and Welfare.
AS rate (ASR): age-standardised rate. See Appendix B: Methods for definition.
Cancer (malignant neoplasm): a term used to describe one of several diseases which result
when the process of cell division, by which tissues normally grow and renew themselves,
becomes uncontrolled and leads to the development of malignant cells. These cancer cells
multiply in an uncoordinated way, independently of normal growth control mechanisms, to
form a tumour. This tumour may expand locally by invasion or systemically by metastasis
via the lymphatic or vascular systems. If left untreated most malignant tumours will
eventually result in death. (See What is cancer? on page 1.)
Cancer death: a death for which the underlying cause is indicated as cancer. Persons with
cancer who die of other causes are not counted in the death statistics in this publication.
CI: confidence interval.
CNS: central nervous system.
Epidemiology: the quantitative study of the distribution and determinants of health-related
states and events in populations, and the application of this study to the control of health
problems.
ICD-9: International Classification of Disease—a coding system used to identify the primary
site of the malignancy. This publication uses the ninth revision of the ICD classification.
Incidence: see new cancer case
ML: myeloid leukaemia.
Mortality: see cancer death
NCSCH: National Cancer Statistics Clearing House.
New cancer case: a person who has a new cancer diagnosed for the first time. One person
may have more than one cancer and therefore may be counted twice in incidence statistics if
it is decided that the two cancers are not of the same origin. This decision is based on a series
of principles set out in more detail in a publication by Jensen et al. (1991).
NHL: non-Hodgkin’s lymphoma.
NOS: not otherwise specified.
NS: nervous system.
NMSC: non-melanocytic skin cancers.
NSW: New South Wales—a State of Australia on the eastern seaboard which has the largest
capital city in Australia, Sydney, and a population of 6,333,515 (1998).
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NT: Northern Territory—a Territory in the north of Australia, with a population of 189,937
(1998) and Darwin as its capital city.
PSA: prostate-specific antigen.
PYLL: person-years of life lost.
Qld: Queensland—a State in the north-east of Australia, with a population of 3,453,477
(1998) and Brisbane as its capital city.
SA: South Australia—a State in the southern part of Australia, with a population of 1,486,418
(1998) and Adelaide as its capital city.
SNOMED: Systematised Nomenclature of Medicine.
Tas: Tasmania—an island State in the south-east of Australia, with a population of 471,700
(1998) and Hobart as its capital city.
Vic: Victoria—a State in the south-east of Australia, with a population of 4,654,937 (1998)
and Melbourne as its capital city.
WA: Western Australia—the western-most State of Australia, with a population of 1,829,145
(1998) and Perth as its capital city.
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Data sources
National Cancer Statistics Clearing House database
Cancer is a notifiable disease in all States and Territories. The data are collected by cancer
registries and include clinical and demographic information about people with newly
diagnosed cancer. This information is obtained from hospitals, pathologists, radiation
oncologists, cancer treatment centres and nursing homes.
The AIHW is responsible for the national collection of cancer incidence statistics through the
National Cancer Statistics Clearing House. National statistics are available for all years from
1982 to 1998.
National mortality database
Registration of deaths in Australia is the responsibility of the State and Territory Registrars
of Births, Deaths and Marriages. Information on the cause of death is supplied by the
medical practitioner certifying the death or by a coroner. Other information about the
deceased is supplied by a relative or other person acquainted with the deceased or by an
official institution where the death occurred. Registration of death is a legal requirement in
Australia, and compliance is virtually complete.
The Registrars provide deaths data to the ABS for coding and compilation into national
statistics. The AIHW also holds these data without unique identifiers in a national mortality
database.
New Zealand data
The incidence and mortality data for New Zealand was supplied by the New Zealand
Health Information Service. Incidence data was supplied for 1997 and mortality data for
1998.
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